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Epilepsy is more frequent in sub-Saharan Africa than the rest of the world due to high levels 
of brain infections by larvae of the pig cestode Taenia solium, a condition termed 
neurocysticercosis. Despite the large nature of the problem, little is known about how 
neurocysticercosis modulates neuronal responses to result in the development of seizures. In 
this thesis I have used the cestode Taenia crassiceps to develop multiple in vitro and in vivo 
models of neurocysticercosis in rodents. Utilising patch-clamp electrophysiology in 
organotypic hippocampal brain slices and chronic, wireless electrocorticographic recordings 
in freely moving animals I have explored how cestode larvae affect neuronal excitability in the 
brain across a range of time scales. First I demonstrate that homogenate of Taenia crassiceps 
larvae has a strong, acute excitatory effect on neurons, which is sufficient to trigger seizure-
like events. The excitatory component of the homogenate was found to strongly activate 
glutamate receptors and not acetylcholine receptors nor acid-sensing ion channels. An 
enzymatic assay showed that the larval homogenate contains high levels of glutamate, 
explaining its acute excitatory effects on neurons. In the second part of my thesis I 
demonstrate that longer-term incubation of Taenia crassiceps homogenate with organotypic 
brain slices over the course of a day does not affect the intrinsic properties of pyramidal 
neurons nor the excitability of the neuronal network. In the final part of my thesis I established 
an in vivo model of neurocysticercosis. I found that intradermal inoculation together with 
multiple intracerebral injections of Taenia crassiceps homogenate did not result in the 
development of seizures over 3 months of chronic electrocorticography recordings. In addition, 
the seizure-threshold to picrotoxin, an excitotoxin, was not altered by Taenia crassiceps 
homogenate injection. Immunohistological analysis of the tissue below the injection site 
revealed no difference in astrocytes nor the number of microglia. However, microglial 
processes were observed to be retracted in the Taenia crassiceps group reflecting a moderate 
neuroinflammatory response. Together the data in my thesis provides novel insight into the 
acute and chronic effects of Taenia crassiceps homogenate on the excitability of neuronal 
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 DISORDERS OF THE NERVOUS SYSTEM AND THEIR PREVALENCE IN THE 
DEVELOPING WORLD 
Neurological disorders contribute 6.3% to the global burden of disease in terms of disability-
adjusted life years and constitute 11.7% of total deaths, according to the most recent, but 
dated, World Health Organisation (WHO) report focusing on neurological disorders and the 
public health challenges they are associated with (WHO, 2006, pages 34-35). 
These include; epilepsy, cerebrovascular disease, Alzheimer’s and other dementias, 
neuro-infections, Parkinson’s disease, nutritional deficiencies and neuropathies, multiple 
sclerosis, neurological injuries, migraine, poliomyelitis, tetanus, meningitis and Japanese 
encephalitis (WHO, 2006). Many are life threatening if left untreated while others result in an 
extremely diminished quality of life. 
Parasitic infections of the nervous system are an important cause of neurological disease, but 
are significantly understudied as they predominantly occur in the developing world, where 
limited resources are available (Singhi 2011; Hotez et al. 2008; Wagner and Newton 2009).      
Parasitic infections affecting the nervous system are more common in children and are 
particularly problematic as they can cause permanent deficits in learning and memory with 
debilitating long-term socioeconomic impacts (Mafojane et al. 2003; Ndimubanzi et al. 2010).  
Neurocysticercosis (NCC) is the most prevalent parasitic infection of the central nervous 
system (CNS) (Diop et al. 2003; Preux and Druet-cabanac 2005) and is listed as one of the 
WHO’s prioritised 20 most Neglected Tropical Diseases (“Neglected Tropical Diseases”, 
accessed July 2019). 
 
 NEUROCYSTICERCOSIS: ITS IMPACT AND PREVALENCE 
NCC is the leading cause of acquired epilepsy in the developing world (Mejia Maza et al. 
2019). It is thought to account for 50 000 deaths annually and up to 70% of those infected will 
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eventually develop seizures (Preux and Druet-cabanac 2005; Román et al. 2000). It is caused 
by larvae of the tapeworm Taenia solium lodging in the brain (Trevisan et al. 2016). 
1.2.1 Prevalence 
NCC is most prevalent in the developing world, spanning the continents of South America, 
Africa and Asia (see Figure 1.1). In addition, it is increasingly becoming apparent in developed 
countries as people emigrate in search of better prospects.  
 
Figure 1.1 Prevalence of Neurocysticercosis. 
Areas in the world endemic to Taenia solium and in which Neurocysticercosis is prevalent, taken from a WHO 
fact sheet (“Endemicity of Taenia solium ” 2015, accessed August 2019).  
NCC is a difficult disease to diagnose definitively as it requires a computed tomography (CT) 
scan, which is expensive and not typically accessible in rural areas where the disease is 
endemic (Mafojane et al. 2003; Ndimubanzi et al. 2010). Furthermore NCC can remain 
asymptomatic for years and as such is likely to be heavily under diagnosed in both rural areas 
and the urban areas to which people have relocated (Stringer et al. 2003; Y. Sun et al. 2014). 
South Africa has a paucity of studies which have attempted to estimate the prevalence of 
NCC, and yet it is one of the more studied populations on the African continent (Mafojane et 
al. 2003). 
A 1965 report by Heinz and MacNab estimates that on average 10% people living in rural 
areas have cysticercosis (infection of the body with T. solium larvae). Cysticercosis may not 
be specific to the brain but since the larvae preferentially penetrate brain and muscle tissue it 
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is likely that NCC will develop (Carpio, Escobar, and Hauser 1998). In a study of 200 male 
black African mine workers, 9.5% had Taenia eggs in their stool, which, if combined with 
improperly managed sanitation, creates a large risk for NCC infection (Bird, Heinz, and 
Klintwork 1962; Garcia and Del Brutto 2005).  
The prevalence of NCC may be as high as 20% in certain regions of South Africa, most notably 
the Eastern Cape, where free-range pig farming is common (Heinz and MacNab 1965; 
Campbell and Farrell 1987). This area is so endemic that one study conducted at the Groote 
Schuur Hospital in Cape Town (over 1200 kilometres away) found that 88% of patients 
presenting with NCC over a 15 year period (N = 239) were originally from the Eastern Cape 
region (A. J. G. Thomson 1993). 
Cysticercosis is an eradicable disease but, unfortunately, no longer features on the 
International Task Force for Disease Eradication’s list of focal diseases (“International Task 
Force for Disease Eradication,”, accessed July 2019) despite previously being designated as 
such (International Task Force for Disease Eradication 2008).  
1.2.2 The Taenia parasite life cycle 
Neurocysticercosis infection occurs when a person accidentally ingests Taenia solium eggs 
from human faecal matter, often via unwashed vegetable produce in areas where pigs are in 
close proximity to humans and sanitation is poor, or if there is a tapeworm carrier in the 
household (Figure 1.2, left) (Diop et al. 2003; Garcia and Del Brutto 2005). Since tapeworm 
are hermaphroditic and each proglottid comprises both gonads, they are able to self-fertilise 
their eggs once they mature. When the tapeworms eggs are fertilised the proglottid is known 
to be gravid (Figure 1.2, right) and is shed into the faeces where the individually encapsulated 
eggs may then be eaten by the intermediate host (Willms and Zurabian 2010). The parasite 
eggs are converted to larvae or oncospheres when they come into contact with the host’s 
gastric acid and intestinal juices and attach to the host’s intestinal mucosal membrane with 
projections of their membrane (Johnston et al. 2016; Verastegui et al. 2015). They secrete 
proteases in order to facilitate burrowing through the membrane in order to enter the 
circulatory system where they are able to travel to other bodily tissues, preferentially the brain, 
skeletal muscle, eye and subcutaneous tissue (Nash et al. 2015; Mahanty and Garcia 2010; 
Carpio, Escobar, and Hauser 1998; Id et al. 2018). 
The oncospheres, upon entry into the brain, form cysticerci. The development of the cysticerci 
is divided into four stages; the vesicular or viable stage, the colloidal stage, the granular-


















Figure 1.2 The Taenia Parasite. 
Left: Life cycle of Taenia solium. (1) A person eats undercooked, infected meat and an adult tapeworm develops in the intestine and (2) sheds gravid proglottids with eggs in their host’s faeces.  
(3) The eggs in the stool are ingested by the designated intermediate host, the pig, or (4) they are ingested by an accidental intermediate host, the human, resulting in human (neuro)cysticercosis.  
(Diagram modified from Rasamoelina-Andriamanivo, Porphyre, and Jambou 2013). Right: Tapeworm recovered from a 30 day hamster infection, whole mounts stained with carmine red. (A) the 
head (scolex) and initial formation of proglottids, (B) immature proglottid, (C) mature ‘gravid’ proglottid showing eggs (Diagram from Willms and Zurabian 2010). 
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The exact mechanism by which NCC leads to epilepsy is largely unknown. It has been 
hypothesized that seizures develop as a result of the host’s immune response to dying cysts, 
as live parasites are associated with negligible inflammation (Stringer et al. 2003; Y. Sun et 
al. 2014). However, it has not been determined whether the mediator of the seizures is a 
substance released by the dying parasite or one produced by the surrounding inflammatory 
cells (Stringer et al. 2003). The stage of the cysticerci may also play a role. 
1.2.2.1 Cyst stages and seizure development 
The host will generally remain asymptomatic, for weeks to months, while the vesicular 
cysticerci mature (Foyaca-sibat et al. 2009). This is suggested to be because the parasite is 
able to use host molecules to mask their surface structures and secrete immunomodulatory 
molecules (Restrepo et al. 2001; Dzik 2006). Following the sequencing of the Taenia solium 
genome in 2013 other evolved adaptions were discovered, including a specialised 
metabolism, nutrient scavenging abilities and specific detoxification pathways (Tsai et al. 
2013). 
Once the cysticerci begin to die, the resulting focal reaction can result in acute symptomatic 
seizures for some (around 7.5%) and in others triggers the beginning of the inflammatory 
process, which can result in seizures, or remain asymptomatic for years, or even the entire 
lifetime of the host (Foyaca-sibat et al. 2009; Stringer et al. 2003). The progression from a 
mature cyst to a colloidal or inflamed cyst is often referred to as the ‘silent period’ (Figure 1.3) 
(Garcia, Gonzalez, and Gilman 2003). 
Fully inflamed cysticerci, over the course of approximately a month, go on to produce a chronic 
granuloma (amalgamation of immune cells and parasite material), resulting in the so-called 
granular-nodular stage (Figure 1.3) (Garcia, Gonzalez, and Gilman 2003). It can take over a 
year for the granuloma to eventually calcify (Figure 1.3) (Garcia, Gonzalez, and Gilman 2003). 
The calcification corpuscle, made up of host protein taken up by the parasite (Flores-Bautista 
et al. 2018), can lead to the formation of an epileptogenic zone in approximately half of people 
(Diop et al. 2003). The manifestation of phenotypical symptoms is variable and may only occur 
4 - 5 years after infection in some cases (Stringer et al. 2003; Y. Sun et al. 2014), seizures 
may also either be generalized or partial depending on the brain area affected (Diop et al. 
2003; Agnes Fleury et al. 2004). 




Figure 1.3 The evolution of parenchymal cysticerci in the accidental human host. 
(A) MRI of vesicular cysticerci. (B) MRI of colloidal (inflamed) cysticerci. (C) MRI of a degenerating cysticercus 
forming a granuloma. (D) CT scan of calcified cysticerci. (Images from Carpio and Romo 2014 and Lange, 
Mahanty, and Raimondo 2018). 
Importantly, the exact correlation between cyst stage and symptom presentation, mainly 
seizures, is still not clear. It is generally believed, however,  that seizures are more likely when 
a degenerating cyst is present (colloidal or granular-nodular stages) (Verma et al. 2010) or 
when the cyst has calcified (Nash, Pretell, and Garcia 2002). In contrast, there is evidence 
that seizures can also occur whilst the cysts are viable. For example, Naidoo et al. (1987) 
found that 12.9 % of epileptic patients with NCC had only viable cysts (N = 70), whereas 
Campbell and Farrell (1987) found this percentage to be 18.5 % (N = 106).  In addition, 
evidence of calcified cysts has also been found in asymptomatic individuals (Prasad et al. 
2009) and Foyaca-sibat et al. (2009) have shown a similar distribution of parasite load and 
degenerating stages of the cyst (past the vesicular stage) in both symptomatic and 
asymptomatic people with NCC. It should be noted that these studies are relatively old and 
improved CT scanning imaging resolution together with the advent of MRI will allow for more 
accurate staging of cysts in order to better correlate cyst development with seizure onset.  
As described above, although the propensity for seizure development may change depending 
on the time since infection and the cyst-stage, it is clear that seizures can occur at any point. 
The variability in terms of when, or whether, seizures emerge suggests that there are likely 
multiple mechanistic processes involved in the development of seizures in NCC. This thesis 
therefore studies the effects of tapeworm homogenate over a range of different time scales to 
explore different possible processes which may be relevant to the epileptogenic process in 
NCC. 





The main symptom of NCC is seizures, either focal or generalized, often resulting in epilepsy, 
which is characterised by recurrent seizures in a person. In fact, the correlation between NCC 
and epilepsy is so well established that NCC is widely recognised as the leading cause of 
acquired epilepsy in adults (Preux and Druet-cabanac 2005; Román et al. 2000). It is 
estimated that between 30 and 50 % of all adult-onset or acquired epilepsy in developing 
countries is due to NCC (Garcia and Del Brutto 2005; Garcia, Gonzalez, and Gilman 2003; 
Ndimubanzi et al. 2010).  
One of the more recent reviews collating incidence of NCC among epilepsy patients in eastern 
and southern african regions found numbers mostly in agreement with the above (Mafojane 
et al. 2003). Those that had lower incidence were often relying solely on serological testing 
which is known to underestimate numbers (Mafojane et al. 2003). In many areas the 
prevalence is still unknown or is on the rise after not being considered endemic for decades 
prior (Mafojane et al. 2003).  
In South Africa the number of epilepsy patients who also have a tapeworm infection in endemic 
areas is similar to the international picture, with Naidoo et al. (1987) finding 30 % of patients, 
Campbell and Farrell (1987) finding up to 50.9 % of patients, Foyaca-sibat et al. (2009) finding 
between 37 and 47 % of patients and van As and Joubert (1991) finding 28 % of patients to 
be infected. Furthermore, studies of epileptic children who also had NCC found a prevalence 
of 43 % in one study (Thomson et al. 1984) and 45.2 % in another of under 20 year olds 
(Foyaca-sibat et al. 2009). The local data is therefore consistent with international studies 
which find that on average, in endemic areas, approximately 29 % of people with epilepsy 
have NCC (Ndimubanzi et al. 2010). 
1.2.3.2 Other 
Other symptoms include; increased intracranial pressure, which can result in migraines, 
headaches and dizziness; focal neurological deficit; meningo-encephalitis and hydrocephalus 
(Nash, Pretell, and Garcia 2002; Prasad et al. 2008; Thomson et al. 1984).  
The symptoms of NCC are often specific to the number of cysts and brain location affected, 
particularly in cases where the larvae enter the ventricles of the brain, which can result in the  
larvae obstructing the flow of cerebrospinal fluid (García et al. 2003; Prasad et al. 2008). Focal 
deficits occur depending on what brain tissue degenerates as a result of the space occupied 
by and inflammatory effects of the calcified cyst. 
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 SEIZURES AND EPILEPSY 
Epilepsy constitutes a serious medical condition whereby bouts of excessive, synchronous 
hyperexcitability (seizures) result in significant morbidity and mortality. It can be genetic in 
origin, result from an anoxic incident, from a CNS infection or trauma or a combination of 
multiple insults. 
The WHO estimates that epilepsy accounts for 0.5 % of the global burden of disease and that 
close to 80 % of all cases occur in the developing world (WHO 2006; Diop et al. 2003). In fact, 
epilepsy is the most common neurological disorder in sub-Saharan Africa (Winkler et al. 2009). 
The syndrome affects many more people in the developing world, ≥ 190 per 100 000 people 
compared to only 24 per 100 000 people in Europe, due to the high incidence of head trauma 
and NCC (WHO 2006, page 58). The prevalence of epilepsy in South Africa is even higher 
and was found to affect between 220 and 370 per 100 000 people in two rural populations 
(N = 400 000)  (Diop et al. 2003; Bird, Heinz, and Klintwork 1962). 
Epilepsy is highly stigmatised in sub-Saharan Africa. The afflicted person can be believed to 
have been cursed with bad spirits which, furthermore, are believed to be contagious, which 
can result in social isolation from the village (Winkler et al. 2009). Not only does this have an 
immense emotional impact but it can also be medically dangerous for someone who is 
epileptic to live entirely alone.  
Status epilepticus is another possible complication of epilepsy caused by NCC. Status 
epilepticus is a continous seizure, or a state of sequential seizures without recovery of 
consciousness. It is considered a medical emergency and can result in debilitating 
neurological sequelea if not treated urgently. 
The brain mechanisms that go awry to result in seizures and ultimately epilepsy are complex, 
and are best understood as network disruptions resulting from alterations to specific brain cell 
types and transmembrane ion gradients, amongst a host of other factors. 
 
 NEURAL SIGNALLING AND THE EXCITATION: INHIBITION BALANCE 
The brain is arguably one of the most complex signalling systems known.  Successful neural 
transmission relies upon a stable balance of excitatory and inhibitory signalling. Neurons, the 
basic computational units of the CNS, are densely connected, each receiving thousands of 
synaptic inputs, and are able to sense changes in the environment, translate these changes 
to other cells and evoke a bodily response (Bear, Connors, and Paradiso 2007). Although 
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neurons do the bulk of informational processing, glial cells are also essential to the functioning 
of neural transmission and their role will be examined in section 1.5.   
1.4.1 Different neuronal types 
This balance between excitatory and inhibitory activity in the brain depends upon the 
collaborative actions of many different cell types and many different neuron types. Activation 
of a neuron typically results in the release of neurotransmitter from the axon terminal into the 
synaptic cleft and the activation of ligand-gated receptors on the postsynaptic neuron, causing 
current flow and voltage signals that may or may not result in an output known as an action 
potential (Bear, Connors, and Paradiso 2007). Different types of neurons release many 
different neurotransmitters (typically only one kind of neurotransmitter per neuron) which have 
different effects on their postsynaptic targets (Bear, Connors, and Paradiso 2007).  
Pyramidal neurons are large cells abundant in the cerebral cortex and hippocampus. They 
serve as the primary excitatory neurons in the brain and release the neurotransmitter 
glutamate. Ubiquitous across the brain are inhibitory interneurons, which function to quieten 
the network by releasing the inhibitory neurotransmitter γ-aminobutyric acid (GABA). Broadly 
speaking these two cell types control the firing rates and excitability of neuronal networks 
(Bear, Connors, and Paradiso 2007). 
1.4.2 Transmembrane ion gradients  
How each synaptic input results in a voltage change in the postsynaptic neuron is down to the 
action of ion channels and transmembrane ion gradients (Raimondo et al. 2015). The opening 
of channels allows ions, which are charged, to move down their electrochemical gradient and 
by doing so change the membrane voltage of the cell. If more positive ions, such as sodium 
(Na+) or calcium (Ca2+), flow into the cell this raises the membrane voltage or ‘depolarises’ the 
cell. Conversely when chloride (Cl-) ions flow into the cell or K+ ions flow out of the cell this 
lowers the membrane potential or ‘hyperpolarises’ the cell. Ion gradients are maintained 
between channel openings by the actions of enzymatic pumps and transporters. The most 
fundamental of which is the Na+ / K+ ATPase enzyme, which utilises the energy from ATP to 
establish opposing transmembrane gradients for Na+ and K+ (Raimondo et al. 2015). This is 
characterised by a high intracellular K+ concentration (typically ~100 mM) and a low 
extracellular concentration (typically ~3 mM) (Raimondo et al. 2015). The opposite is true for 
Na+ where the intracellular concentration is low (typically ~10 mM) and the extracellular 
concentration is high (~145 mM) (Raimondo et al. 2015). A host of secondary transporters 
then use these gradients established by the Na+ / K+ ATPase enzyme to establish 
transmembrane gradients for other ions such as Cl- (Raimondo et al. 2015). 
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Ion channels harness these ion gradients to generate ion flux and voltage signals in neurons. 
Ion channels are often gated, meaning that their opening is dependent on an environmental 
signal. For example, some ion channels are ligand-gated whilst others may be voltage-gated 
(Bear, Connors, and Paradiso 2007). Ligand-gated ion channels are specific to the type of 
neurotransmitter that binds to them, whereas voltage-gated ion channels are only able to open 
at certain voltages (Bear, Connors, and Paradiso 2007).  
Voltage-gating is in fact critical for the generation of an action potential in the postsynaptic 
cell. An excitatory post-synaptic potential causes some depolarisation of the membrane which 
can lead to the opening of voltage-gated Na+ channels (Bear, Connors, and Paradiso 2007). 
If enough voltage-gated Na+ channels are activated, the resulting depolarisation leads to 
further opening of voltage-gated Na+ channels initiating a positive feedback phase whereby 
rapid depolarisation, constituting an action potential, is generated. With continued 
depolarisation, voltage-gated Na+ channels start to close again. At the same time voltage-
gated K+ channels also open allowing K+ to flow out of the cell (repolarising and then 
hyperpolarising the cell) (Bear, Connors, and Paradiso 2007). This second phase is critical for 
the cell’s ability to respond to subsequent signalling.  
Some ion channels may exhibit both voltage-gated and ligand characteristics. For example, 
the N-methyl-D-aspartate (NMDA) receptor, which is effectively a hybrid ligand and voltage-
gated glutamate receptor. At hyperpolarised potentials a magnesium molecule blocks the 
channel pore. At  depolarised potentials  the magnesium molecule is displaced which means 
that concurrent glutamate binding will open the channel (Bear, Connors, and Paradiso 2007). 
Thus in order for the channel to be open, it needs both glutamate binding and a relatively 
positive membrane potential.   
K+ leak-channels are constitutively open ion channels and play a critical role in setting the 
negative membrane potential of neurons by allowing K+ to flow down its electrochemical 
gradient from inside to outside the cell (Lesage 2003). Raising the extracellular K+ 
concentration is a common method for inducing seizure-like activity in vitro as it slows the K+ 
flux through the leak channels by creating a less steep ion gradient, thereby depolarizing the 
neuronal resting membrane potential (Wang et al. 2016). Furthermore, genetic alterations to 
K+ channels are known to result in inherited epilepsies (Villa and Combi 2016). At least 80 
genes in the human genome encode for K+  channels, which represents the largest of the ion 
channel groups (Villa and Combi 2016).   
1.4.3 Different receptor types and neurotransmitters 
Different receptors respond to different neurotransmitters released from the presynaptic 
neuron resulting in either a depolarisation or hyperpolarisation of the postsynaptic cell. The 
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correct functioning of these receptors helps maintain the balance of excitation and inhibition 
in the network. 
1.4.3.1 Glutamate receptors 
Glutamate is the main excitatory neurotransmitter in the CNS and has three main ionotropic 
or fast acting receptors; AMPA, NMDA and Kainate receptors (Bear, Connors, and Paradiso 
2007). All three are cation channels that result in a depolarisation, but each is selective for 
which cations it allows through its channel. AMPA and Kainate receptors are permeable to 
Na+, K+ and sometimes Ca2+, whereas NMDA channels are permeable to Na+, K+ and Ca2+ 
(Bear, Connors, and Paradiso 2007). An imbalance resulting in an increased activity of these 
channels could result in runaway excitation or even seizure development. Especially because 
NMDA receptors are voltage-gated and thus open for longer than AMPA receptors allowing 
for much more Ca2+ influx which in turn can stimulate further neurotransmitter release. In fact 
glutamate is so potent in its effect that astrocytes assist neurons in buffering it out of the 
synaptic cleft once it has been released. 
1.4.3.2 Acetylcholine receptors 
While the neurotransmitter, acetylcholine plays a more complex role in the central nervous 
system, it is also released at the neuromuscular junction where it is responsible for muscle 
contraction. It has a broadly depolarising effect on both pyramidal neurons and inhibitory 
interneurons resulting in a combination of excitatory and inhibitory effects on the network 
(McQuiston 2014). There are two types of acetylcholine receptors: nicotinic and muscarinic. 
Nicotinic receptors are ionotropic (permeable to Na+, K+ and Ca2+)  mixed cation channels and 
are responsible for fast synaptic transmission (Bear, Connors, and Paradiso 2007). 
Conversely, muscarinic channels are metabotropic and responsible for much slower 
transmission, mediated by second messenger cascades (Bear, Connors, and Paradiso 2007). 
The nicotinic receptors are therefore the more likely of the two to result in any kind of excitation 
imbalance, either through direct excitation of pyramidal neurons or reduction in nicotinic 
activation of interneurons. Additionally if the GABAergic interneurons become transiently 
excitatory in nature during seizures, through a process known as chloride loading (Raimondo 
et al. 2012), then acetylcholine release and activation of these interneurons could also 
conceivably contribute to a pro-seizure environment. 
1.4.3.3 Acid Sensing Ion Channels  
Acid Sensing Ion Channels (ASICs) are a type of cation channel, permeable mainly to Na+ but 
also somewhat to Ca2+ that have a depolarising effect when activated. They are activated at 
low pHs (maximally at a pH of 5) due to proton binding. In addition, they have also been known 
to be bound by other molecules that can activate or inhibit them outside of their usual pH range 
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(Baron, Waldmann, and Lazdunski 2002; Weng et al. 2004; Osmakov et al. 2017). There are 
at least two types of ASICs currently known to be expressed in the hippocampus (Baron, 
Waldmann, and Lazdunski 2002; Weng et al. 2004). 
Relevant to this thesis, tissue acidosis is a common feature following seizures as well as 
ischemia and may activate ASICs (Johnson et al. 2001), indicating a potential role in the 
modulation of network excitability. Therefore any sort of activation of ASICs leads to some 
excitation and should a seizure occur the resulting tissue acidosis may lead to prolonged 
ASICs activation which may in turn further propagate the seizure state. 
1.4.3.4 Substance P receptors 
Substance P is a peptide widely abundant in the peripheral nervous system, where it is 
responsible for the neurogenic inflammatory response (Douglas and Leeman 2011). Its 
function in the CNS, however, is associated with sensory transmission, pain, inflammation, 
stress related responses, depression and anxiety (Douglas and Leeman 2011). Its multiple 
roles means that it is likely relevant in the modulation of excitability in the context of 
neuroinflammation (Robinson et al. 2012), as will be discussed in section 1.5.  
Substance P binds to the Neurokinin-1 receptor (NK1R), which is a G-protein coupled 
metabotropic receptor that acts as a neuro-immune modulator and can lead to the activation 
of enzymes and secondary messenger cascades. Furthermore, activation of the NK1R results 
in Nuclear Factor Kappa-light-chain-enhancer of activated B cells (NF-κB) activation and 
cytokine production (Douglas and Leeman 2011). NK1Rs are constitutively expressed in 
inhibitory interneurons in the hippocampus, among other brain regions (Sloviter et al. 2001; 
Chun et al. 2019; Martin and Sloviter 2001). Substance P is expressed in the terminals of 
hippocampal principle neurons, but possibly only during seizure states (Liu et al. 2002).  
Since Substance P receptors are found on interneurons, it is predicted to have an inhibitory 
effect, however, the exact mechanisms of Substance P’s action remains unclear. For example, 
Substance P can result in effects further afield by enhancing the function of NMDA channels 
and increasing intracellular Ca2+ in the granule cells of the dentate gyrus, the cells which 
control activation of the whole hippocampal network (Lieberman and Mody 1998). The large 
number of Substance P positive fibres relative to the small number of cells expressing 
Substance P receptors in the hippocampus suggests that Substance P may be exerting some 
of its effect by non-synaptic diffusion (Czeh et al. 2005). This may be how it affects the NMDA 
receptors of the granule cells, causing them to remain open for longer, and resulting in an 
overall excitatory effect, in contrast to its prior mentioned inhibitory action (Czeh et al. 2005). 
All things considered it is plausible that the dysregulation of Substance P could result in a pro-
seizure environment.  
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 NEUROINFLAMMATION AND NETWORK EXCITABILITY 
Neuroinflammation is a state characterised by the activation of glial cells, including microglia 
and astrocytes, as well as the release of cytokines. It may originate in the brain or be acquired 
systemically through a disruption of the blood-brain barrier (BBB). 
1.5.1 Glial cells 
Microglia are the main immune surveillance cells of the CNS and respond to disruptions in 
balance, whether resulting from a seizure or foreign particulate entering the CNS (Y. Sun et 
al. 2014). They also function to enhance synapse activity and thus have a critical role in 
maintaining network synchronization (Akiyoshi et al. 2018). Furthermore, activated microglia 
produce various cytokines that can be strongly seizure promoting (Rana and Musto 2018; 
Shabab et al. 2017). Activation of microglia, following neuroinflammation, results in a 
phenotypic change, specifically the enlarging of the soma and the retracting of branched 
processes (Hui et al. 2019), as shown in Figure 1.4. 
Figure 1.4 Morphology of activated microglia. 
Microglia labelled with an anti-Iba1 antibody in sham-operated (left, C & J) and lesioned (right, D & K) rat brains 
demonstrating some of the phenotypic characteristics of activated microglia; retracted processes and reduced 
arbourisation. Images taken from Hui et al. (2019, figure 6).  
Astrocytes are ubiquitous throughout the CNS and serve many functions under normal 
conditions including; metabolic support for neurons, glutamate and pH buffering, maintenance 
of the extracellular environment and BBB formation (Sofroniew 2005). Astrocytes become 
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reactive in response to CNS stress, such as that following trauma, ischemia or infection, where 
they play a critical but not fully understood role during the neuroinflammatory process 
(Sofroniew 2015). An activated astrocyte’s morphology predominantly involves an increase in 
size, through the increase of a structural protein, glial fibrillary acidic protein (GFAP), as 
demonstrated in Figure 1.5. Astrocytes are known to form functional barriers that reduce the 
spread of immune and inflammatory cells, but can also be neurotoxic and pro-inflammatory 
by releasing cytokines such as interleukin-1β (IL-1β), interleukin-6 (IL-6) and tumour necrosis 
factor-α (TNF-α) (Sofroniew 2015; Rana and Musto 2018). Glial cells play an important role 
during inflammation and their interactions with neurons, effected via cytokines, distinctly 
govern the transition to seizure states (Diaz Verdugo et al. 2019). 
Figure 1.5 Morphology of activated astrocytes. 
Astrocytes labelled with an anti-GFAP antibody in lesioned brain tissue (right) and in the non-lesioned 
contralateral hemisphere (left) demonstrating the morphology changes associated with inflammation and 
activation. Images taken from Wilhelmsson et al. (2006, figure 1). Scale bar 25 µm. 
1.5.2 Pro-inflammatory cytokines 
Pro-inflammatory cytokine proteins are produced by glial cells and neurons as part of the 
brain’s inflammatory response. Once produced, they go on to stimulate the release of further 
inflammatory cytokines which can, if not regulated by anti-inflammatory processes, have 
detrimental effects on CNS function. 
IL-1β is a pro-inflammatory cytokine released by classically activated microglia as well as 
astrocytes and functions to increase neuronal excitability, either by stimulating glutamate 
release from astrocytes or by increasing calcium influx through neuronal NMDA receptors 
(Viviani et al. 2003; Alyu and Dikmen 2017). IL-1β has also been shown to significantly 
decrease GABA-signalling in human temporal lobe epilepsy, which further promotes 
pathological neuronal excitability (Roseti et al. 2015). Furthermore, an increase in IL-1β has 
been found in the brain following seizures (Alyu and Dikmen 2017; Balosso et al. 2008) and 
its inhibition has been shown to reduce seizure propensity (Maroso et al. 2011). 
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TNF-α is another cytokine which plays an important role in neuronal excitation, with differential 
mechanisms observed in the different glial cell types. When TNF-α is released by activated 
astrocytes, it reduces neuronal inhibition through the endocytosis of GABA receptors in the 
dendritic spines of pyramidal neurons (David Stellwagen and Malenka 2006; D. Stellwagen et 
al. 2005). When released by microglia, TNF-α increases excitation by upregulating AMPA 
receptors (David Stellwagen and Malenka 2006). In addition, TNF-α has been found in the 
serum of children with febrile seizures at a significantly higher rate than in children that 
presented with a fever and no accompanying seizures (El Sabbagh et al. 2017). 
IL-6 is a pro-inflammatory cytokine released by microglia, astrocytes, endothelial cells and 
neurons and is largely upregulated in response to other cytokines, such as TNF-α and IL-1β 
(Erta, Quintana, and Hidalgo 2012). It has protective effects, including its essential role in the 
conversion of innate to adaptive immune responses (Jones 2005). IL-6 also causes gliosis 
and increased body temperature, which may have neurotoxic effects (Erta, Quintana, and 
Hidalgo 2012). IL-6 is known to contribute to epileptogenesis through reducing, in particular, 
effective hippocampal neurotransmission and neurogenesis (Rana and Musto 2018). 
Furthermore IL-6 production appears to correlate with increased neuronal injury (Ravizza et 
al. 2005). 
1.5.3 Blood-brain barrier 
BBB permeability is increased by inflammation-induced cytokine release, such as that of IL-1β, 
TNF-α and IL-6,  and allows albumin (not usually found in the brain) to permeate into the 
parenchymal tissue (Rana and Musto 2018). This has been shown to impair astrocytic 
buffering of extracellular potassium and glutamate leading to increased neuronal excitability 
(Van Vliet et al. 2007; Seiffert et al. 2004). 
1.5.4 Link between neuroinflammation and seizures 
Inflammation and epilepsy have been shown to be closely linked, with each increasing the 
likelihood of the other (Vezzani et al. 2011). For example, Rasmussen’s encephalitis, a 
disorder in which there is inflammation of the cerebral cortex, is characterised by focal seizures 
that are often drug-resistant (Varadkar et al. 2014). In addition, inflammatory markers, or 
cytokines, have been found in the excised brain tissue of human epileptic patients (Sheng et 
al. 1994) and experimentally have been found to be elevated after the occurrence of a seizure 
(Ravizza et al. 2005; M. G. De Simoni et al. 2000). Experimental seizure models indeed show 
an upregulation of pro-inflammatory cytokines and inflammation (Balosso et al. 2008) and 
models of inflammation result in, or increase the propensity for, seizures (Cerri et al. 2016).  
Further evidence shows that inflammation and network excitability are intricately related, 
which is pertinent to many of the known causes of acquired epilepsies where inflammation 
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may play a role. This is particularly relevant to NCC because it is still not clear as to whether 
the mechanism by which NCC leads to seizures involves a substance released by the dying 
parasite or whether it is the host’s inflammatory response to the parasite that leads to seizures, 
or both.  
Live parasites are able to modulate neuroinflammation and can be immunosuppressive (Y. 
Sun et al. 2014). For instance, soluble factors produced by helminths were shown to block the 
pro-inflammatory effects of lipopolysaccharide (LPS), an endotoxin commonly used 
experimentally to evoke inflammatory responses (Y. Sun et al. 2014). However, even when 
parasites are able to functionally mask their presence inflammatory markers can often be 
detected (Nguekam et al. 2003; Restrepo et al. 2001). Furthermore, the strength of the 
immune response to helminths seems to correlate with seizure severity (Singhi 2011; 
Restrepo et al. 2001; Herrick et al. 2018; Prasad et al. 2009). Thus it seems clear that 
neuroinflammation may play a significant role in the development of seizures in NCC.   
 
 CURRENT MODELS OF NEUROCYSTICERCOSIS 
NCC is a complex disease to model because both the tapeworm organism and the host, as 
well as the interaction between the two, need to be modelled. This adds multiple layers of 
complexity. In addition, an ideal model would need to capture the fact that humans are 
accidental intermediate hosts for T. solium in the disorder.   
1.6.1 Tapeworm species 
With regard to the species of tapeworm that can be used to study NCC, there are a large 
variety that are specialised to infect particular primary and intermediate hosts. The most 
commonly used species are: Taenia solium (T. solium), which have evolved to infect humans 
(primary) and pigs (intermediate); Taenia crassiceps (T. crass.), which infects wild canines 
(primary) and small mammals such as rodents (intermediate); and Mesocestoides corti (M. 
corti), which has evolved to infect canines and felines (primary) and small mammals, reptiles 
and birds (intermediate). Working with an organism infective to humans has obvious biosafety 
concerns, which is why most work on T. solium involves observational studies of naturally 
infected humans or pigs (Lange, Mahanty, and Raimondo 2018). M.corti and T.crass. have 
both been used in previous studies to model and study NCC.  
M. corti is a popular model for ease of use in the laboratory, as the larval stage can be 
maintained entirely in culture (Vendelova et al. 2016). It is also small enough to allow for 
relatively easy intracranial inoculation of rodents, which can be a challenge with the other 
species. There are, however, significant drawbacks to using M.corti in models of NCC. For 
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example, it is not of the same genus as T. solium and T. crass. which makes it more likely to 
differ in antigenicity (Matos-Silva et al. 2012). Furthermore its natural life cycle never enters 
the CNS of its host (Lange, Mahanty, and Raimondo 2018) and when injected into the CNS 
artificially it can proliferate and invade the brain, as opposed to ultimately degenerating and 
calcifying as is naturally observed in NCC (Matos-Silva et al. 2012).  
T. crass. is a model organism that is not only similar enough to T. solium to be useful, but is 
also relatively easy to work with in the laboratory. Its antigenic similarity to T. solium  has been 
known as far back as the nineties (Sciutto et al. 1990) but has recently been further supported 
by the sequencing of the T. solium genome (Tsai et al. 2013). T. crass. does not usually infect 
humans (Willms and Zurabian 2010), and interestingly the ORF strain of T. crass. has lost the 
ability to mature into the adult worm stage and therefore does not pose an infection risk to 
animals. This extensively used ORF strain is also able to asexually divide in the intermediate 
host by budding off into new larvae, which can be maintained in culture for a few weeks (Willms 
and Zurabian 2010). This makes it fairly easy to maintain a laboratory colony. The larvae of 
T. crass. are large (roughly the same size as T. solium), however, and can be difficult to use 
with rodent models. Another drawback is that morphological and genetic changes tend to 
accrue with asexual reproduction as is the case with the ORF strain. A final challenge that 
occurs when choosing a model species that is different to the one that infects humans (T. 
solium) is the likelihood of species specific immune responses and particular antigens 
expressed between the parasite and the host. Overall, however, T. crass. is the most attractive 
cestode to use in the laboratory, as it is sufficiently similar  to T. solium without that organism’s 
biosafety concerns.  
1.6.2 In vivo models 
In order to assess current in vivo models of NCC, 57 original research papers found on 
PubMed were reviewed. Of these, only 11 met the criteria for an in vivo model of NCC (see 
Table 1.1). Only studies that administered the parasitic organism (either T. solium or T. crass.) 
in a controlled way, so as to give the cohort a similar base level of infection, were included. 
This excluded a significant number of studies which used naturally infected pigs, identified by 
tongue examination. It also excluded all human studies as none provided detail on the number 
of cysticerci found in each of the patients and therefore it was not possible to determine the 
original parasite load. Most in vivo studies of NCC tend to be observational and exploratory 
and there is a definitive lack of studies focusing on experimental models of NCC, which is what 
this thesis aimed to address.  
Table 1.1 provides a summary of the 11 in vivo studies that met the inclusion criteria. The 
majority of the studies used parasite material which was injected into the host in the viable 
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form, which corresponds to when a human host would be asymptomatic. This is with the 
exception of Robinson et al. (2012) and Stringer et al. (2003), who intracranially injected rats 
with homogenised granuloma material, that had been generated in the peritonea of mice. This 
corresponds to when a host would likely be symptomatic.  Focussing on replicating the stage 
of the disease of interest may be critical as NCC is such a long-term disorder to model, taking 
years for seizures to develop in the human host.  
Further, the time course of each experiment is an important factor to consider and depending 
on the measured outcomes, this may need to be for a long period in order to capture the full 
course of the disease. Seizures for example may only manifest during later stages. 
Interestingly, very few of the models analysed in Table 1.1 investigated seizure occurrence 
and of the 6 studies that did, a large variation in experimental recording time was found, 
ranging from hours (Stringer et al. 2003; Robinson et al. 2012) to months (Saleque et al. 1988; 
Verastegui et al. 2015; Agnès Fleury et al. 2015) to almost a year (De Aluja et al. 1996). In 
addition, it is important to distinguish the observation of seizures behaviourally from directly 
measuring electrocorticographic (ECoG) or electroencephalographic activity for evidence of 
seizures 24 hours a day. Of concern is that the frequency of seizures observed behaviourally 
may be an underestimate of total seizure burden because, it is typically not possible to observe 
animals behaviourally 24 hours a day and furthermore seizures may not always generalise, 
therefore behavioural symptoms may not always be observed during focal seizures. This 
thesis addresses this issue by developing an in vivo model that utilises wireless telemetry to 
record ECoG continuously over several months, combined with automated seizure detection 
algorithms to detect seizure activity over this period. 
Finally there is the question of modelling NCC in vivo in the correct host. In NCC, humans act 
as both the primary and the accidental intermediate host. There is also a case for using 
intermediate hosts to model the disorder. For example, Trevisan et al. (2016) showed that 
pigs, which are the intermediate host of T. solium, can also develop seizures, suggesting that 
there might be a similar progression of NCC disease mechanisms in the primary and the 
intermediate host.  
Given the lack of studies that have investigated and modelled NCC in vivo this thesis aims to 
develop an in vivo model of NCC (see Aim 3). In addition, this thesis also investigated the 

























Up to 3 
months 
Intermediate host 
No attempt to observe possible seizures, only 
histopathology 
Matos-Silva 
et al, 2012 
Experimental encephalitis caused by Taenia 
crassiceps  cysticerci in mice 
Mouse T. crass Cysticerci Unknown 1 month 
Intermediate host 
No attempt to observe possible seizures, only 
biochemical analysis 
Leandro et 
al,  2014 
Partial reverse of the TCA cycle is enhanced in 
Taenia crassiceps  experimental 
neurocysticercosis after in vivo treatment with 
anthelminthic drugs 
Mouse T. crass 
Metacestode 
fraction (from 
peritoneal fluid of 
infected mice) 
Unknown 45 days 
Intermediate host 
No attempt to observe possible seizures,  
only neuro-histopathology 
Modelling cysticercosis rather than NCC  
(ip or sc injections) 
Zepeda et al,  
2017 
Apoptosis of mouse hippocampal cells induced 







Yes 6 hours 
Intermediate host  
Granuloma material generated in mouse – 
concern for cross-species reactivity 
Robinson et 
al, 2014 
Substance P causes seizures in 
neurocysticercosis 




Yes 1 hour 
Intermediate host  
Granuloma material generated in mouse – 
concern for cross-species reactivity 
Stringer et al, 
2003 
Epileptogenic activity of granulomas 
associated with murine cysticercosis 




4 - 6 
months 
Not natural intermediate host 
Very low number develop seizures (9%)  
Verastegui et 
al, 2015 
Novel rat model for neurocysticercosis using 
Taenia solium  
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Rat T. solium 
Postoncospheral 





Not natural intermediate host 
No attempt to observe possible seizures, only 
immunological analysis 
Palma et al, 
2019 
In vitro model of postoncosphere development, 
and in vivo infection abilities of Taenia solium 
and Taenia saginata 
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Not natural intermediate host 
No attempt to observe possible seizures,  
only neuro-histopathology 
Mejia Mazza 
et al, 2019 
Axonal swellings and spheroids: a new insight 
into the pathology of neurocysticercosis 




No seizures detected (long time period) 
De Aluja et 
al, 1996 
Experimental Taenia solium cysticercosis in 
pigs: characteristics of the infection and 
antibody response 
Pig T. solium 










Kinetics of circulating antigens in pigs 
experimentally infected with Taenia solium 
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No seizures or neurological  
manifestations detected 
Very low infection efficiency (≤5.4% from a 
subarachnoid intracranial injection of 1000 
activated oncospheres) 
Fleury et al, 
2015 
Taenia solium : Development of an 








Not a natural host  
(but most similar to humans) 
Saleque et 
al, 1988 
Induced neurocysticercosis in rhesus monkeys 
(macaca mulatta) produces clinical signs and 




1.6.3 In vitro models 
In contrast to the few in vivo studies in the NCC research field to date, many in vitro studies 
have been performed. Most have focused on immune mechanisms such as changes in the 
expression of cytokines and chemokines. 
In vitro studies of NCC typically rely on blood samples taken from NCC-positive patients and 
controls. Immune cells, typically lymphocytes, are isolated from the blood and challenged with 
some form of tapeworm material to see how they respond (Amit et al. 2011; Prasad et al. 
2009). The effects of monocytes that have been stimulated by tapeworm material have been 
tested on other cell types, including astrocytes, so as to ascertain Taenia-induced astrocytic 
release of chemokines and other immunomodulatory molecules (Uddin et al. 2005). In 
addition, a fair amount of research has been devoted to the analysis of histological 
preparations of brain tissue from pigs and rodents, as well as humans (Mejia Maza et al. 2019; 
Christensen et al. 2016; Matos-Silva et al. 2012; Zepeda et al. 2017; Robinson et al. 2012). 
Other common methodologies include using a human or non-human cell line exposed to 
T. solium harvested from the muscle of naturally infected swine (Palma et al. 2019; Chile et 
al. 2016) as well as exposing different fractions or components of the parasite material to the 
cultured cells (Uddin et al. 2005, 2010; Amit et al. 2011). For example, Amit et al. (2011) found 
that only the cyst fluid antigen elicited a significant immune response. 
To the best of my knowledge, no in vitro studies to date have investigated the effect of 
tapeworm material on the functionality of neuronal networks in situ. Since previous literature 
is largely skewed towards analysing the immune response, a further aim of this thesis was to 
study the electrophysiological properties of neurons in the presence of tapeworm material (see 
Aim 1 and Aim 2). It is hypothesised that if the acute or relatively sustained presence of Taenia 
larval material were able to alter neuronal membrane properties and ion fluctuations, activate 
particular neurotransmitter receptors, or modulate network excitability in an intact slice of 
brain, this would be relevant to the likelihood of seizures developing in vitro. 
1.6.4 Gaps in the current understanding of NCC 
Although a reasonable amount of research has been performed investigating how Taenia is 
able to impact the brain and immune system, there are significant gaps that require further 
investigation.  
NCC has a lengthy disease progression, which is difficult to model. Experimental studies of 
disease progression or symptom development after the tapeworm larvae have died have been 
limited as compared to observational studies. In addition, homogenised (dead) T.crass. larval 
material has not been used in any in vivo studies to date and has had limited use in vitro for 
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testing the immune response to tapeworm. Therefore in this thesis I almost exclusively utilised 
homogenised T.crass. larvae, to determine what effect the components of freshly killed larvae 
have on neurons and neuronal networks.  
The accurate measurement of seizures in experimental models is another area, which has not 
been well studied. This is likely due to the difficulty and cost associated with 
electrophysiological equipment. Of the 6 studies in which the presence or absence of seizures 
was noted (Table 1.1), only 2 used intracranial electrodes, and in these measurement periods 
were very short (hours) (Stringer et al. 2003; Robinson et al. 2012). The 4 other studies simply 
reported whether seizures were detected, presumably by observation, and few defined 
phenotypic behaviours for classifying seizures (Verastegui et al. 2015; De Aluja et al. 1996; 
Agnès Fleury et al. 2015; Saleque et al. 1988). Since seizures are the most common symptom 
of NCC it is of great import to be able to correctly identify and document them. 
Finally, while some studies have fractionated Taenia homogenate and identified the properties 
of certain fractions (Uddin et al. 2005, 2010; Amit et al. 2011), the exact excitatory molecule/s 
have yet to be elucidated. Identifying the excitatory component, and which neurotransmitter 
system it is activating, would go some way towards answering how Taenia parasites are able 
to cause seizures in the brain. 
In light of the gaps in the literature described above, my research sought to further investigate 




Aim 1: Investigate the short-term effect of Taenia crassiceps homogenate on neurons in vitro. 
Aim 2: Investigate the long-term effect of Taenia crassiceps homogenate on neurons in vitro. 
Aim 3: Investigate the chronic effect of Taenia crassiceps homogenate in vivo. 
 
  




1.8.1 Aim 1 Investigate the short term effect of Taenia crassiceps homogenate on 
neurons in vitro (chapter 3) 
1.1 Establish a colony of tapeworm. 
 1.2 Determine the acute effect that T. crassiceps has on neurons. 
 1.3 Determine whether the depolarizing effect of T. crassiceps is ionically mediated. 
1.4 Ascertain which neuronal receptors mediate the depolarizing effect of 
T. crassiceps. 
1.8.2 Aim 2 Investigate the long-term effect of Taenia crassiceps homogenate on 
neurons in vitro (chapter 4) 
 2.1 Investigate the effect of T. crassiceps on neuronal membrane properties. 
 2.2 Determine the effect of T. crassiceps on the active firing properties of neurons. 
 2.3 Quantify the effect of T. crassiceps on sodium and potassium currents in 
neurons. 
2.4 Explore the effect of T. crassiceps on the seizure threshold of neuronal networks 
in vitro. 
1.8.3 Aim 3 Investigate the chronic effect of Taenia crassiceps homogenate in vivo 
(chapter 5) 
 3.1 Establish the technology for chronic ECoG recordings in freely moving rats. 
 3.2 Characterise recorded ECoG activity patterns including induced seizure activity. 
 3.3 Determine whether T. crassiceps results in seizures/seizure-like activity in vivo. 
3.4 Evaluate the effect of T. crassiceps on the seizure threshold of neuronal networks 
in vivo. 





2 MATERIALS AND METHODS 
Most of the methods detailed below were set up for the first time in Africa and as such required 
significant optimisation. All reagents used were supplied by Thermo Fischer Scientific, unless 
otherwise stated. 
All animal handling, care and procedures were carried out in accordance with South African 
national guidelines (South African National Standard: The Care and Use of Animals for 
Scientific Purposes 2008) and with approval from the University of Cape Town Animal Ethics 
Committee (Protocol No: AEC 015/015, AEC 014/035, AEC 016/005). All animal rooms were 
maintained between 22 - 24 °C, with a lux of 100 - 300 and food and water available ad libitum.  
 TAENIA MAINTENANCE AND PREPARATION OF WHOLE CYST HOMOGENATE  
2.1.1 Intraperitoneal infection 
Larvae of T. crass. (ORF strain) were donated to us by Dr Siddhartha Mahanty (NIH, Maryland, 
USA) and propagated in vivo by serial intraperitoneal infection of 5 - 8 week old female 
C57BL/6 mice. Females were used simply because they could be easily group housed without 
fighting. The small, translucent, motile larvae were selected in phosphate buffered saline 
(PBS, pH 7.4; Sigma-Aldrich) and injected into 8 mice (20 larvae per mouse) in order to 
maintain the colony. Every 3 months parasites were harvested by peritoneal lavage, as 
similarly described by Mahanty, Madrid, and Nash (2013), and washed 6 times in PBS before 
further processing. This procedure was carried out in an experimental room to which the 
animals were habituated before the harvesting or injection procedures. The weight of the mice 
was tracked weekly during the 3 months of infection. 
2.1.2 Preparation of homogenate 
For the preparation of T. crass. whole cyst homogenate, larvae were stored immediately after 
harvesting at -80 °C. Later these were thawed (thereby lysing the cells) and suspended in 
PBS (1X) containing a protease cocktail inhibitor (1 % vol / vol, Sigma-Aldrich) at a larval:PBS 
ratio of 1:3. The larvae were then homogenised on ice using an homogenizer (Polytron, PT 
2500E, Kinematica). The resulting mixture was centrifuged (Eppendorf, 5810 R) at 4000 rpm 
for 20 minutes at 4 °C. The liquid supernatant (between the white floating layer and solid pellet) 
was collected and filter sterilized through a 0.22 µm size filter (Millex-GV syringe filter, Merck). 
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This supernatant was then aliquoted and stored at -80 °C until use. To assess whether large 
or small molecules were responsible for the excitation of neurons, a portion of the whole cyst 
homogenate was dialysed using a Slide-A-Lyzer™ dialysis cassette (3 kDa MWCO, 
Separations) in 2l of standard artificial cerebro-spinal fluid (aCSF) at 4° C (see below for 
composition). The aCSF solution was changed twice over 24 hours. To determine the ionic 
composition of T. crass. whole cyst homogenate a Cobas 6000 analyser (Roche) was used, 
with ion specific electrodes for K+ and Na+. A Mettler Toledo SevenCompact™ pH meter 
(S210, Merck) was used to determine the pH of the homogenate. 
For the preparation of T. solium whole cyst homogenate, larvae of T. solium were harvested 
from the muscles of a heavily infected, freshly slaughtered pig (performed by Ulrich Fabien 
Prodjinotho). After extensive washing with sterile PBS (1X), T. solium larvae were suspended 
in PBS containing phenylmethyl-sulphonyl fluoride (5 mM) and leupeptin (2.5 μM ) at a 
larval:PBS ratio of 1:3. Larvae were then homogenised using a sterile hand held homogenizer 
(T10 Basic Ultra-Turrax, IKA-Werke) at 4 °C. The resulting homogenate was sonicated 
(Sonopuls HD 2070.2, Bandelin Electronic) (4 x 60 s at 20 kHz, 1 mA, with 30 s intervals) and 
gently stirred with a magnetic stirrer (Corning PC-420D, Corning) for 2 hours at 4 °C. 
Thereafter it was centrifuged (Sigma 3-16KL Refrigerated centrifuge, SciQuip Ltd) at 15,000 g 
for 60 min at 4 °C and the liquid supernatant (between the white floating layer and solid pellet) 
was collected. The supernatant was filtered through 0.45 μm size filters (Millex GV syringe 
filter, Merck), aliquoted and stored at -80 °C. All T. crass. and T. solium larval products were 
assessed for protein concentration using a BCA protein or Bradford’s assay kit, respectively 
(Merck). 
Anja De Lange performed the assessment of daily glutamate production in which both 
T. crass. and T. solium larvae were placed into 12-well plates (±15 per well, of roughly 5 mm 
length) with 2 ml of culture medium (Taenia solium medium: RPMI 1640 (Sigma-Aldrich) with 
10 mM HEPES buffer (Sigma-Aldrich), 100 U/ml penicillin (Sigma-Aldrich), 100 μg/ml 
streptomycin (Sigma-Aldrich), 0.25 μg/ml amphotericin B (Sigma-Aldrich) and 2 mM 
L-glutamine (Whitehead Scientific); Taenia crassiceps  medium: Earles Balanced Salt Solution 
(EBSS, Sigma-Aldrich) with 100 U/ml penicillin, 100 μg/ml streptomycin, 11.4 U/ml nystatin 
(Sigma-Aldrich), and 2 mM glutamax). Every 24 hours 1ml of culture media was collected from 
each well, stored at -80 °C, and replaced with fresh culture medium. The concentration of 
glutamate was measured using a glutamate assay kit according to the supplier’s instructions 
(Sigma-Aldrich). 
 
CHAPTER 2. Materials and Methods 
26 
 
 HIPPOCAMPAL BRAIN SLICE PREPARATION 
Organotypic brain slices were prepared using 6 - 8 day old male Wistar rats and C57BL/6 mice 
following the protocol originally described by Stoppini et al., (1991). Males were used to 
exclude any possible variable effect of the oestrus cycle on results. Rats and mice were 
transported to the tissue culture laboratory in the afternoon and allowed to habituate before 
the procedure. Brains were extracted and swiftly placed in cold (4 °C) dissection media 
consisting of EBSS supplemented with 6.1 g/l of HEPES, 6.6 g/l of D-glucose and 200 µl of 
saturated sodium hydroxide (all from Sigma-Aldrich). The hemispheres were separated and 
individual hippocampi were removed and immediately cut into 350 m slices using a Mcllwain 
tissue chopper (Brinkmann, Mickle). Cold dissection media was used to rinse the slices before 
placing them onto Millicell-CM membranes (Sigma-Aldrich). Slices were maintained in culture 
medium consisting of (vol / vol); 23 % EBSS, 50 % MEM with glutamax, 25 % heat-inactivated 
horse serum (Biochrom), 2 % B27 and 6.5 g/l glucose (all from Sigma-Aldrich unless otherwise 
stated). For some experiments T. crass. (50 µg/ml) or LPS (10 µg/ml) was added to the media 
for 24 hours. Slices were incubated in a 5 % carbon dioxide (CO2) humidified incubator at 
between 35 – 37 °C. Recordings were made after 6 - 14 days in culture, as this is the ideal 
time for the slice to have recovered from the slicing procedure (the tissue debris have cleared) 
but it is not so old that recurrent connections are common, which may result in the slice being 
more excitable (A. De Simoni and Yu 2006). I elected to use slices from the hippocampus for 
the in vitro experiments because of the reliability of the hippocampal organotypic brain slice 
culture preparation and because the hippocampus is often involved in the development of 
seizures (A. De Simoni and Yu 2006).  
 
 ELECTROPHYSIOLOGY 
2.3.1 In vitro patch-clamp recordings 
Brain slices were transferred to a submerged recording chamber on a patch-clamp rig, which 
was maintained at a temperature between 28 and 30 °C, and were continuously superfused 
with standard aCSF bubbled with carbogen gas (95 % O2: 5 % CO2) using peristaltic pumps 
(102R, Watson-Marlow Fluid Technology Group). The standard aCSF was composed of: NaCl 
(120 mM); KCl (3 mM); MgCl2 (2 mM); CaCl2 (2 mM); NaH2PO4 (1.2 mM); NaHCO3 (23 mM) 
and D-Glucose (11 mM) in deionised water with pH adjusted to between 7.35 - 7.40 using 0.1 
mM NaOH (Sigma-Aldrich). Neurons in the CA3 region of the hippocampus were visualized 
using a Zeiss Axioskop or Olympus BX51WI upright microscope using 20x or 40x 
water-immersion objectives and targeted for recording. Micropipettes were prepared (tip 
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resistance between 3 and 7 MΩ) from borosilicate glass capillaries (outer diameter 1.2 mm, 
inner diameter 0.69 mm, Harvard Apparatus Ltd) using a horizontal puller (Sutter). Recordings 
were made in current clamp mode using Axopatch 200B amplifiers (Axon Instruments) and 
data acquired using WinWCP (University of Strathclyde) or Igor (Markram Laboratory, Ecole 
polytechnique fédérale de Lausanne). Traces were analysed using custom scripts in Matlab 
(R2015b, MathWorks). Two internal solutions were used: a “standard” internal solution (K-
gluconate (126 mM), KCl (4 mM), HEPES (10 mM) Na2ATP (4 mM), NaGTP (0.3 mM) and 
Na2-phosphocreatine (10 mM); Sigma-Aldrich) and a “caesium” internal solution (CsOH (120 
mM), Gluconic acid (120 mM), HEPES (40 mM), Na2ATP (2 mM), NaGTP (0.3 mM) and NaCl 
(10 mM); Sigma-Aldrich).  
In addition to the patch pipette, for puffing experiments a secondary “puffer‟ pipette was pulled 
with the same tip resistance as the patch pipette. Experimental substances were then puffed 
onto neurons using an OpenSpritzer, a custom made pressure ejection system (Forman et al. 
2017). For these experiments current was injected if required to ensure a neuronal resting 
membrane potential within 2 mV of -60 mV. In all puffing experiments each data point 
represents the mean peak puff-induced change in membrane potential from 10 sweeps. In 
some experiments tetrodotoxin (TTX, 2 µM) was added to the aCSF to block voltage-gated 
sodium channels.  
To test intrinsic properties of slices treated for 24 hrs with T. crass. homogenate or LPS (see 
Chapter 4), whole-cell current clamp and voltage clamp recordings were made using the 
standard internal solution and aCSF. 
Pharmacological manipulations were performed by bath application of drugs using a perfusion 
system. Mecamylamine hydrochloride (10 µM, #2843, WhiteSci), Amiloride hydrochloride 
hydrate (2 mM, #A7410, Sigma-Aldrich), D-AP5 (50 µM, #010610, WhiteSci) and CNQX 
disodium (10 µM, #1045, WhiteSci) were purchased from Tocris. Kynurenic acid was acquired 
from Sigma-Aldrich. As Substance P has no known blocker it was applied directly onto the 
recording cell using the OpenSpritzer (100 µM, #S-6883, Sigma-Aldrich).  
2.3.2 Calcium imaging 
For calcium imaging, organotypic hippocampal mouse brain slices were virally transfected with 
a genetically-encoded Ca2+ reporter (GCAMP6s under the synapsin promoter, 
AAV1.Syn.GCaMP6s.WPRE.SV40) one day post culture using the OpenSpritzer and imaged 
5 days later using an Olympus BX51WI microscope, 20x water-immersion objective, CCD 
camera (CCE-B013-U, Mightex) and 470 nm LED (Thorlabs). Images were collected using 
µManager (Edelstein et al. 2010) and analysed using Caltracer3 beta scripts in Matlab.  
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2.3.3 In vivo wireless telemetry 
Stereotaxic surgery was performed on 14 male Wistar rats (4 of which were a pilot study) 
weighing between 400 and 450 g, as described by (Snowball et al. 2019). Anaesthetised rats 
(isoflurane in oxygen; Induction: 5 % at 2 l/min, maintenance 2.5 - 1.5 % at 1.5 l/min, Safeline) 
were placed in the stereotaxic frame (Kopf) and burr holes were drilled at the following 
locations relative to bregma; X: +3 mm, Y: -7 mm for the recording electrode, X: -2.60 mm, 
Y: -4.44 mm for the reference electrode and X: +2 mm, Y: -0.8 mm for the fixing screw. 
Thereafter an Open Source Instruments (OSI) A3028E ECoG transmitter was implanted 
subcutaneously over the dorsum with the attached wires extending subcutaneously up to the 
cranium where the recording and reference electrodes were positioned through each burr hole 
approximately 0.5 mm into the brain parenchyma. Each electrode was secured in place with 
either a screw or a cannula (Plastics One), to allow for the intracranial injections beginning 
after 2 weeks of baseline recording. The screws and cannulae were fixed in place with dental 
cement (Ivodent) forming a small, circular headpiece and the dorsum was closed with nylon 
suture material (Ethicon). Post-operative medication and pain management included a second 
Buprenorphine dose (8 hours following the pre-surgery dose), Meloxicam (Boehringer 
Ingelheim, 1mg/kg) administered subcutaneously for 3 days, EMLA cream (AstraZeneca) for 
the dorsum incision, 2ml saline (VetServ) subcutaneously and eye gel (Aspen, also used 
throughout the surgery). The room where the surgical procedures were performed was 
separated from the room in which the rats’ were housed by a connecting room in which the 
preparation for the surgery took place (injections, weighing etc.). Rats were habituated to the 
procedure room and were transferred to the surgery room once anaesthetised. After the 
surgery, whilst recovering from anaesthesia they were kept under a warming light in the 
procedure room until they could be returned to their home cage. 
Rats were individually housed (2 cages side-by-side) in custom built Faraday cages to 
facilitate recording. Welfare monitoring was conducted twice per day for 7 days, thereafter 
once daily. Rats were weighed daily for 4 days, thereafter weekly. One rat was euthanased 8 
weeks into the experiment as he had damaged his headpiece irreparably.  
2.3.3.1 Injections 
After two weeks of baseline ECoG recording, animals were injected via the guide cannula with 
either T. crass. homogenate or saline (with 15 endotoxin units, equivalent to the T. crass. 
sample). Rats were anaesthetised and injected in the same procedure and surgery rooms as 
used previously. Injections were made into the right hemisphere V1 cortex (X +3 mm and Y -7 
mm relative to bregma, Z -1 mm from the pia) for all 10 rats and for half of the rats an additional 
2 injection sites (dorsal hippocampus and V2 cortex) in the left hemisphere (X -2.6 mm and 
Y -4.44 mm relative to bregma, Z -3.2 mm and Z -1 mm from the pia) as shown in Table 2.1. 
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In practicality the z co-ordinates had an additional 8 mm (the length of cannula above the skull) 
as they were counted from when the needle first entered the cannula. Once the needle was 
lowered to each injection site it was left in place for 2 minutes. Thereafter 3 injections of 200 nl 
each were made, at approximately 100nL/min, with a 1 minute wait in between, a 5 minute 
wait at the end and an additional 5 minute wait once the needle had been raised to the position 
of the bottom of the cannula. As each injection site was to receive 3x 200 nl, the injections 
were made at 3 micro-locations around the site. For example, for the V1 site (Z-1 mm) the 
injections were made at 1.1, 1.0 and 0.8 mm down into the brain. This was to ensure an even 
delivery and better diffusion of the T. crass. or saline from the needle tip. Each rat had 3 
intracranial injection sessions, for which the animal was anesthetised, every 2 weeks (Figure 
2.1). For the third intracranial injections, the injection volume was doubled. During the first 
intracranial injection all rats (T. crass. injected and saline injected) also received an 
intradermal injection of 100 µl of T. crass. homogenate in Freund’s incomplete adjuvant (1:1) 
into each hind limb. The Freund’s incomplete adjuvant allows the antigen of interest (in this 
case T. crass. homogenate) to be gradually released in order to facilitate a peripheral immune 
response. 
24 hours prior to sacrifice a seizure threshold test was performed in which each rat was lightly 
anesthetised and was injected with 400 nl of 10 µM picrotoxin, a known pro-convulsant, into 
the visual cortex of the right hemisphere. They were monitored closely both visually and via 
their ECoG for several hours. The picrotoxin dose was intentionally low in order to determine 
if our experimental interventions may have made the animals more vulnerable to picrotoxin 
induced seizures. Of the 10 rats in the experiment, one was lost prior to the endpoint and was 
not included in the seizure threshold test. 
 
Figure 2.1 Experimental timeline of the investigation into the chronic effects of T. crass. 
Injection areas are the V1 cortex (‘V1’), the hippocampus (‘hipp’) and the V2 cortex (‘V2’). 
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Table 2.1 Treatment conditions of rats in the in vivo experiment.
 
 
2.3.3.2 ECoG acquisition and analysis 
The rats were housed in Faraday cages with aerials to collect the ECoG signals. Signals from 
the subcutaneous transmitters (A3028E, OSI), were continuously recorded from the freely 
moving rats using Neuroarchiver software (OSI) for up to 12 weeks (0.3–160 Hz, 
512 samples / s). The raw ECoG was observed and analysed during playback of the archived 
files alongside the ‘Event Classifier’ application in Neuroarchiver. For automated seizure / 
ictal-like event detection, video-ECoG matching was used to identify ECoG events of interest 
associated with an observed behaviour / seizure in order to create an ‘Event library’. The Event 
Classifier application (OSI) was used to do this by classifying 1 s segments of ECoG according 
to several metrics (coastline, intermittency, coherence and spikiness) enabling similar events 
(e.g. chewing artefact, ictal events) to cluster together when plotted according to the metrics. 
My event library was made with at least 50 examples of each type of event (ictal, chewing 
artefact, baseline, scratching headpiece) from at least 8 animals. Definitive ictal activity 
recorded following picrotoxin injection was used to define the ictal event type. This then 
allowed for unbiased identification and quantification of ECoG events recorded over the 12 
week period by automated comparison to the event library (see 
http://www.opensourceinstruments.com/Electronics/A3018/Seizure_Detection.html for further 
details). I compared the number of ictal-like events between T. crass. treated rats and controls. 
A seizure was defined as at least 5 consecutive ictal-like events (i.e. lasting more than 5 s).   
Each seizure was visually confirmed. Data was quantified using Microsoft excel v14 and 
Graphpad Prism 5.  






After 12 weeks rats were anesthetized (Halothane, Safeline) and transcardially perfused with 
PBS followed by paraformaldehyde (4 %) (Sigma-Aldrich). Briefly, the thorax was opened and 
the heart exposed so that a blunted 18-gauge needle (through which PBS and then fixative 
would be pumped) could be inserted into the left ventricle, just lateral to the, being careful not 
to pierce the septum. The right atrium of the heart was punctured, allowing blood to spill out 
of the heart and drain away. The perfusion was judged to be adequate based upon the 
presence of fasciculation in the body and the brain being very white in colour. All perfusions 
were carried out in the morning in a laboratory to which the rats were habituated before the 
procedure began. Brains were post-fixed for 24 hours and then transferred to 30 % sucrose 
(in dH2O), all at 4 °C. Once the brains were fully cryoprotected, judged by an increased density 
i.e. sinking to the bottom of the sucrose solution, they were frozen in Optimal Cutting 
Temperature reagent (Jung) and stored at -80°C until slicing. 
2.4.2 Slicing 
The right hemisphere of each brain was marked in an area of non-interest with a needle. 
Brains were sectioned at -20 °C on a Leica CM 1850 cryostat microtome into 50 µm coronal 
sections. Each brain was sectioned in a posterior to anterior direction using landmarks 
identified with the Paxinos and Watson (2007) rat brain atlas and slices were collected free-
floating into PBS at 4 °C. The two slices which best showed the electrode tract were chosen 
to be stained for each rat, along with 2 more slices from each rat to serve as controls against 
endogenous tissue fluorescence and non-specific antibody binding. 
2.4.3 Staining 
Slices were first permeabilized in PBS containing 3 % triton X-100 (Sigma-Aldrich) for 3x 10 
minutes before blocking for 1 hour (PBS with 1 % triton x-100 and 2 % bovine serum albumin). 
Slices were incubated overnight at room temperature in PBS with 3 % Triton X-100 and 
primary antibodies: mouse anti-GFAP (diluted 1:1000; #G3893, Sigma-Aldrich) and goat 
anti-Iba1 (diluted 1:500; #ab107159, Abcam). After 3x 10 minutes washes in PBS-triton slices 
were incubated at room temperature for 5 hours with PBS-triton and secondary antibodies: 
donkey anti-mouse Alexa 488 (diluted 1:500; #715-546-150, Jackson ImmunoResearch) and 
donkey anti-goat Cy3 (diluted 1:1000; #705-166-147, Jackson ImmunoResearch). After a 
further 3x 10 minutes of washing slices were incubated with PBS containing Hoechst nuclear 
stain (1:1000; #H1399, Thermo Fischer Scientific) for 15 minutes in the dark and then washed 
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for a final 10 minutes in PBS. Slices were mounted using Mowiol mounting medium with 
anti-fade (Sigma-Aldrich) and cover-slipped (B&M Scientific). All slices from all 9 rats were 
stained in the same session.  
Table 2.2 Antibodies used in immunohistochemistry experiment.  
 
2.4.4 Imaging 
Imaging was initially performed using a LSM510 Meta NLO model confocal microscope (Carl 
Zeiss, Zen 2009 software) and a AxioCam MRm camera with a 20x objective (Zeiss) in order 
to acquire a detailed tile, z-stack image of the area just below the electrode tract and 
corresponding area (with the exact same settings) in the adjacent hemisphere. Some 
qualitative images were obtained using a 40x water immersion objective. 
A LSM 880 airyscan confocal microscope (Carl Zeiss, ZEN SP 2 software) with 20x and 63x 
objectives (Zeiss) was used to acquire images for the microglial activation investigation. To 
quantify microglial cell numbers, the 20x objective was used to acquire tiled z-stacks of the 
area immediately surrounding the electrode tract in the right hemisphere. In order to be able 
to quantify microglial morphology, high resolution images were obtained of individual microglia 
(Iba1) using the 63x objective.  
The non-specific binding control and the endogenous fluorescence controls showed no 
staining. A total of 8 rats were included in the immunohistological analysis, as one rat was lost 
prior to the endpoint and for another slice sectioning was incorrectly performed.  




All image processing and quantification was performed using Zen Black 2.3 (Carl Zeiss) and 
Image J 1.52a (NIH). To assess the extent of GFAP (astrocytes) and Iba1 (microglia) labelling 
surrounding the right hemisphere electrode tract, collapsed z-stack tile images were used to 
measure average fluorescence and the average number of pixels above a threshold. To 
quantify the number of pixels above a threshold, a mask tool which removes low level 
background fluorescence in Zen, as shown in Figure 2.2, was used. These measurements 
provide a general indication of the number of each cell type or the size of the cells. Right 
hemisphere measurements were normalised using images from the corresponding left 
hemisphere (where no electrode had been present) in order to correct for absolute differences 
in fluorescence arising during the staining protocol. Two slices (including left and right 
hemispheres) were analysed for each rat.  
 
Figure 2.2 Mask tool in Zen to remove low-level background fluorescence and set a threshold. 
 
Further higher resolution camera images of microglial cell bodies, labelled for Iba1, were 
captured and qualitatively assessed, to compare between T. crass. treated and control slices. 
Features such as the length of the microglial processes and size of cell body were broadly 
compared and informed the need for further, more extensive and quantifiable analysis of the 
microglia. 
Measurements of microglial density, clustering and spacing were performed on collapsed 
z-stack images taken using a confocal microscope, tile images taken of the area surrounding 
the recording electrode, in a manner blind to the condition of the animal, as previously 
described by Hui et al. (2019). One image was analysed for each rat. Each Iba1-labelled 
microglial cell body was marked in its centre with dot in Image J and the number of cells 
automatically generated using the ‘analyze particles’ function. The ‘nearest neighbour’ 
distance plugin was used to determine the shortest distance to any other cell, for every cell. 
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Cellular density was calculated by dividing the total number of cells by the surface area of the 
image (measured in mm2). The spacing index is reported as the (average nearest neighbour 
distance)2 multiplied by the density.  
To assess microglia morphology 20 high resolution confocal images, taken with the 63x oil 
immersion objective of the area surrounding the electrode tract on both sides, were analysed 
per rat. For accuracy, these collapsed z-stack images were only of cells in which the entire 
Iba1-labelled cell body and proximal processes were clearly visible. For each cell, the area of 
the soma was determined using the freehand selection tool in Image J to trace around its 
borders. The polygon tool was used to determine the arbourisation area by joining the tips of 
distal processes. Inputting the length of the scale bar into the ‘set scale’ feature in Image J 
meant the number of pixels could be converted to actual distances. The arbourisation 
circularity index was calculated, from the same drawn polygon, to give an indication of how 
evenly the distal processes extended from the cell body. The morphological index is reported 
as the soma area divided by the arbourisation area. This measurement was of particular 
interest to assess the ‘activation state’ of the cells as microglia in an inflammatory 
environment, for example, are known to shorten their processes and show enlarged cell 
bodies, which would give them a larger morphological index.  
 
 DATA ANALYSIS AND STATISTICS 
Data was graphed and analysed using Matlab R2015b, Microsoft excel v14 and GraphPad 
Prism v5. Adobe Illustrator vCS6 was used to create all figures. 
All data was subjected to a Shapiro-Wilk test for normality and found to be parametric or 
non-parametric.  
2.5.1 Parametric statistical analysis 
The student’s t-test (either paired or unpaired) was used when comparing the means of two 
groups. When comparing multiple groups a one-way analysis of variance (ANOVA) or 
repeated measures ANOVA was used as appropriate. If significant (p < 0.05), this was 
followed with a Tukey’s post hoc test. Data presented as mean and standard error of the mean 
(SEM).  
2.5.2 Non-parametric statistical analysis 
Non-parametric data comparing two groups underwent a Mann Whitney U test if unpaired and 
a Wilcoxin signed ranked pairs test if paired. For multiple comparisons of independent data a 
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Kruskal-Wallis ANOVA was done. For multiple comparisons of paired data a Friedman test 
was performed. If significant (p < 0.05), in either case, this was followed with a Dunn’s Multiple 





3 THE ACUTE EFFECTS OF TAENIA CRASSICEPS ON 
NEURONS IN VITRO 
 INTRODUCTION 
In endemic areas, approximately 29 % of people with epilepsy have NCC (Ndimubanzi et al. 
2010). Despite the impact of NCC, compared to other causes of epilepsy, there are a paucity 
of studies investigating the seizure mechanisms involved (Lange, Mahanty, and Raimondo 
2018). As a result, precisely how cestode larvae cause recurrent seizures is still relatively 
poorly understood.  
In NCC seizures may occur at any stage following initial infection (Garcia and Del 2017).  It is  
thought that inflammatory processes in the brain can play an important role in the development 
of recurrent seizures (Vezzani et al. 2016). Therefore, previous work exploring seizure 
development in NCC has typically focused on how the host neuroinflammatory response to 
larvae might precipitate seizures (Nash et al. 2015; Lange, Mahanty, and Raimondo 2018). 
For example, Robinson et al. (2012) have shown that production of the inflammatory molecule 
and neurotransmitter, Substance P, in peritoneal cestode granulomas can precipitate acute 
seizures. In addition to substances (such as Substance P) produced by the host response, 
cestodes themselves are known to excrete or secrete various products. For example cestode 
larvae derived factors are known to modulate the activation status of immunocytes such as 
microglia and dendritic cells (Y. Sun et al. 2014; Emilia Vendelova et al. 2016). However, 
comparatively little is known about how factors contained in, or secreted by, cestode larvae 
might affect neurons and neuronal networks directly, including whether these may have 
pro-seizure effects. 
To address this, whole-cell patch-clamp recordings and calcium imaging in rodent 
hippocampal organotypic slice cultures was used to explore the direct effects of cestode larval 
products on neuronal activity. I found that the whole homogenate products of Taenia 
crassiceps larvae have a strong, acute, excitatory effect on neurons. This was sufficient to 
trigger seizure-like events in vitro. T. crass. larval dependent neuronal depolarization was 
mediated by glutamate receptor activation and not nicotinic acetylcholine receptors, acid-
sensing ion channels nor Substance P. Direct measurement of glutamate concentration 
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revealed that the homogenate of both T. crass. and T. solium larvae contain high levels of 
glutamate. Finally, we found that larvae of both species produce and release this excitatory 
neurotransmitter into their immediate environment. My findings are relevant for the 
understanding of seizure generation in neurocysticercosis. 
 
 TAENIA CRASSICEPS HOMOGENATE EXCITES NEURONS AND CAN ELICIT 
EPILEPTIFORM ACTIVITY. 
To investigate the potential acute effects of T. crass. larvae on neurons, T. crass. larval 
homogenate was prepared using larvae harvested from the peritonea of mice which were 
freeze-thawed and homogenized (Figure 3.1 A). Whole-cell patch-clamp recordings were 
made from CA3 pyramidal neurons in rodent hippocampal organotypic brain slice cultures and 
pico-litre volumes of T. crass. homogenate were directly applied to the soma of neurons using 
a custom built pressure ejection system (Figure 3.1 A) (Forman et al. 2017). Application of the 
homogenate (20 ms puff) elicited immediate, transient depolarization of the membrane voltage 
in recordings from both rat and mouse neurons (Figure 3.1 B). Increasing the amount of 
homogenate delivered by increasing the pressure applied to the ejection system resulted in 
increasingly large membrane depolarization, which could trigger single or multiple action 
potentials (Figure 3.1 B - C). Similar puffs of artificial cerebrospinal fluid (aCSF) did not affect 
the neuronal membrane potential excluding the possibility that mechanical effects might 
account for the homogenate-induced depolarization I observed.  
To further explore the acute excitatory effect of T. crassiceps   on neurons, neuronal networks 
and the propagation of network activity, Dr Raimondo and I performed fluorescence Ca2+ 
imaging in mouse hippocampal organotypic brain slice cultures. Neurons were virally 
transfected with the genetically-encoded Ca2+ reporter, GCAMP6s, under the synapsin 
promoter and imaged using widefield epifluorescence microscopy (Figure 3.1 D).  To simulate 
a pro-ictal environment, a low Mg2+ aCSF was used (0.5 mM Mg2+)  and neurons in the dentate 
gyrus were imaged whilst small, spatially restricted puffs of T.crass. homogenate were 
delivered every 15 ms using a glass pipette (Figure 3.1 D). The cells within the direct vicinity 
of the puffing pipetted showed a sharp increase in fluorescence immediately following the 
delivery of T. crass. homogenate (Figure 3.1 E t1) for all 3 puffs, indicating Ca2+ entry following 
membrane depolarization and action potential generation. Interestingly, cells in the periphery 
showed notable increases in fluorescence at a delayed interval following some (but not all) 
puffs (Figure 3.1 E t2). The excitation of these cells could only be as a result of being 
synaptically connected to the cells that were exposed to the puff itself, as they were not 
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positioned close enough to the puffer pipette to be directly excited by the homogenate. Indeed 
a current-clamp recording from a neuron in the same slice (Figure 3.1 E inset) indicates that 
a single, spatially restricted puff of T. crass. homogenate is able to elicit the onset of a 
regenerative seizure-like event lasting far longer than the puff itself. Together this indicates 
that T. crass. homogenate results not just in a transient depolarization of cells in the immediate 
vicinity of application, but can trigger a wave of excitation that propagates through the brain 
slice in both space and time. This demonstrates that T. crass. homogenate can initiate 
seizure-like activity under suitable conditions.  
 
 POTASSIUM CONTRIBUTES MODESTLY TO TAENIA CRASSICEPS INDUCED 
NEURONAL DEPOLARIZATION. 
The extracellular concentration of K+ ([K+]e, typically 3 - 4 mM) is considerably lower than the 
intracellular concentration of K+ ([K+]i, typically 100 mM)  within neurons (Jiang and Haddad 
1991), which means that even small changes in [K+]e result in relatively large changes to the 
transmembrane K+ gradient and consequently the reversal potential for K+ (EK+). Due to the 
fact that constitutively activated K+ conductances, or K+ “leak” channels (Lesage 2003), are 
the major contributor to the resting membrane potential, addition of extracellular K+ and 
accompanying changes to EK+ result in membrane depolarization.  
As all cells have a high [K+]i, it is conceivable that the T. crass. homogenate could have a high 
K+ concentration, which would then account for its depolarizing and excitatory effects on 
neurons. To address this, we first directly measured the ionic composition of the T. crass. 
homogenate using a Roche Cobas 6000. The K+ concentration of the T. crass. homogenate 
was 11.39 mM as compared to 3.0 mM in our standard aCSF. The T. crass. homogenate Na+ 
concentration was 123.9 mM and 144.2 mM for the aCSF. Although the K+ concentration is 
higher in the homogenate than the aCSF, the ionic composition more closely reflects that of 
the extracellular as opposed to intracellular compartment. Nonetheless, we set out to 
determine what effect application of 11.39 mM K+ would have on neurons in our system. 
Whole-cell patch-clamp recordings in current clamp mode using a standard internal solution 
and aCSF were made from CA3 pyramidal neurons in rat hippocampal organotypic brain slice 
cultures.  If necessary, current was injected to ensure that the baseline membrane potential 
was within 2 mV of -60 mV. To remove membrane potential fluctuations due to synaptic noise, 
and to prevent regenerative Na+ conductances due to voltage-gated sodium channels, 2 μM  







Figure 3.1 Taenia crassiceps homogenate excites neurons and can elicit epileptiform activity. 
A) Schematic showing the experimental set up in which whole-cell patch-clamp recordings were made from CA3 
hippocampal pyramidal neurons in rodent organotypic slice cultures while a puffer pipette delivered pico-litre 
volumes of homogenised Taenia crassiceps larval homogenate (T. crass. hom.) targeted at the cell soma. B) 
Current clamp recording from a rat pyramidal neuron while increasing amounts of T. crass. homogenate was 
applied via the puff pipette (left to right, orange arrows). Small amounts of T. crass. homogenate resulted in 
depolarization (left), increasing amounts elicited single (middle left) or even bursts of action potentials (middle 
right) whilst a similar puff of aCSF had no effect on the neuronal membrane potential (right, blue arrow), showing 
that potential mechanical disruption of the cell by a puff is not sufficient to depolarise it. C) As in ‘B’, identical 
effects of T. crass. homogenate could be elicited in current clamp recordings from a CA3 hippocampal pyramidal 
neuron in a mouse organotypic brain slice culture. D) Top: widefield fluorescence image of neurons in the dentate 
gyrus of a mouse hippocampal organotypic brain slice culture expressing the genetically-encoded Ca2+ reporter 
GCAMP6s under the synapsin promoter in aCSF containing 0.5 mM Mg2+. A subset of neurons used to generate 
the Ca2+ traces in ‘E’ are indicated by different colours. The orange dotted circle indicates where T. crass. 
homogenate was delivered using the puff pipette. Bottom, schematic of the experimental setup including puffer 
pipette and CCD camera for Ca2+ imaging using a 470 nm LED. E) Top, dF/F traces representing Ca2+ dynamics 
from the GCAMP6s expressing neurons labelled in ‘D’ concurrent with 3 puffs (30 ms duration) of T. crass. 
homogenate 15 s apart. Bottom: two images of raw Ca2+ fluorescence at two time points; t1 and t2. Note how at 
time point t2 neurons distant to the site of T. crass. homogenate application are also activated, indicating spread 
of neuronal activity. Inset, top-right: current clamp recording from a neuron demonstrates that T. crass. 
homogenate application was able to evoke a seizure-like event. 
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TTX was added to the aCSF. Puffs of aCSF containing 11.39 mM K+ were directed toward the 
soma of recorded neurons. Whilst this did cause a depolarization of the membrane potential, 
the effect was modest resulting in a mean positive shift of 0.72 mV (IQR 0.51 - 1.04 mV, N = 8) 
in the membrane potential, which was significantly less than the depolarization caused by 
puffs of T. crass. homogenate (median 10.12 mV, IQR 9.93 - 12.49 mV, N = 5, p = 0.0016, 
Mann-Whitney U test, Figure 3.2 A, B, D). Next, to isolate T. crass. homogenate induced 
depolarization, which was not mediated by K+, we performed whole-cell patch-clamp 
recordings using a caesium based internal solution (see Materials and Methods page 26), 
which blocks K+ channels.  The addition of caesium did not greatly change the positive shift in 
membrane potential caused by T. crass. homogenate (median 13.76, IQR 10.87 - 17.24 mV, 
N = 49, p ≤ 0.0489, Mann-Whitney U test, Figure 3.2 C, D). Together, this indicates that 
although K+ in the T. crass. homogenate does contribute to membrane depolarization, the 
majority of the effect is mediated by a different component. 
 
 TAENIA CRASSICEPS HOMOGENATE INDUCED NEURONAL DEPOLARIZATION 
IS MEDIATED BY A SMALL MOLECULE. 
Next, to determine the fraction of the T. crass. homogenate, which underlies the acute 
excitatory effect on neurons we observed, we used a dialysis membrane to separate the 
fraction of the homogenate bigger than 3 kDa from the total homogenate. To do so we used a 
3 kDa dialysis cassette incubated overnight in standard aCSF. This effectively removed 
molecules smaller than 3 kDa from the homogenate. When this dialysed T. crass. homogenate 
containing only the fraction bigger than 3 kDa was puffed onto the cells in the same recording 
conditions as in Figure 3.2 B and C, the depolarizing response was greatly reduced 
(p ≤ 0.0003, Mann-Whitney U test, Figure 3.3 A - C). The median positive shift in membrane 
potential for dialysed T. crass. homogenate was only 0.27 mV (IQR 0.20 - 0.85 mV, N = 5) as 
compared to a median of 13.76 mV (IQR 10.87 - 17.24 mV, N = 49) for the total homogenate 
(Figure 3.3). This indicates that the excitatory component of the T. crass. homogenate is a 
molecule smaller than 3 kDa. 
  




Figure 3.2 Potassium contributes modestly to Taenia crassiceps induced neuronal depolarization. 
(A) Whole-cell patch-clamp recording using a standard internal in current clamp mode from a CA3 pyramidal 
neuron in a rat organotypic hippocampal slice culture. A 20 ms puff of T. crassiceps homogenate (T. crass. hom.)  
(orange arrow) directed at the cell soma is delivered via a puffer pipette, causing depolarization. B) As in ‘A’ but 
puffing aCSF containing 11.39 mM K+ (equivalent to the K+ concentration of T. crass. homogenate) caused 
modest depolarization. 2 μM TTX was added to the aCSF to reduce synaptic noise in the voltage trace.  C) As in 
‘A’ but with a caesium based internal electrode solution to block K+ channels and 2 μM TTX in the aCSF. Puffs of 
T. crass. homogenate (orange arrow) resulted in sizeable depolarization. D) Population data showing that the 
response from the 11.39 MM K+ puff was significantly smaller than the T. crass. homogenate (with and without 
caesium internal). Values with means ± SEM; *** p ≤ 0.001, each data point represents a cell. 




Figure 3.3 Taenia crassiceps homogenate induced neuronal depolarization is mediated by a small 
molecule.   
Whole-cell patch recordings in current clamp mode were made from CA3 pyramidal neurons in rat organotypic 
hippocampal slice cultures using a caesium based internal in the presence of 2 μM TTX. A)  Delivery of a puff of 
T. crassiceps homogenate (T. crass. hom.) caused a depolarizing shift in membrane potential. B) The depolarizing 
response to T. crass. homogenate was largely abolished by dialysing out all molecules smaller than 3 kDa. C) 
Population data demonstrating that the T. crass. homogenate response is significantly reduced by dialysis, 
indicating that the excitatory component is a small molecule (< 3 kDa). Values with means ± SEM; *** p ≤ 0.001, 
each data point represents a cell.  
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 TAENIA CRASSICEPS HOMOGENATE INDUCED NEURONAL DEPOLARIZATION 
IS NOT MEDIATED BY NICOTINIC ACETYLCHOLINE RECEPTORS, ASIC 
RECEPTORS, OR SUBSTANCE P. 
Our results demonstrate that the T. crass. derived small molecule induces neuronal 
depolarization very rapidly (within ms), as such, it is highly likely that this molecule is an agonist 
of a neuronal ionotropic receptor. Therefore, we utilized pharmacological methods to 
determine the ionotropic receptor system via which the T. crass. derived small molecule acts. 
Nicotinic acetylcholine receptors (nAchRs) are well described ionotropic receptors in the 
nervous system, which mediate depolarization via a mixed Na+, K+ conductance (Bear, 
Connors, and Paradiso 2007). Again, using a caesium based internal solution in the presence 
of TTX in the aCSF, CA3 neurons were whole-cell patched and the peak voltage during 
T. crass. homogenate induced neuronal depolarisation measured before, during and after 
bath application of the non-competitive nicotinic acetylcholine receptor antagonist 
mecamylamine hydrochloride (10µM) to block nAchRs (Figure 3.4 A). The blockade of nAchRs 
did not significantly alter the T. crass. homogenate induced depolarisation. The median 
T. crass. homogenate induced depolarization was 16.28 mV (IQR 13.54 - 23.63 mV) during 
baseline, 16.58 mV (IQR 11.21 - 24.50 mV) in the presence of mecamylamine hydrochloride 
and 13.20 mV (IQR = 10.37 - 23.48 mV) following washout (N = 5, p > 0.05, Friedman test, 
Figure 3.4 A, B). 
Acid-Sensing Ion Channels (ASICs) are proton-gated sodium channels known to be 
expressed by hippocampal neurons and result in neuronal depolarization when activated. We 
therefore considered that the pH of the T. crass. homogenate may be important as acidic 
conditions could activate ASICS and cause neuronal depolarization. We measured the pH of 
the T. crass.  homogenate (mean = 7.99), which was too alkaline to activate ASICs, activated 
maximally at a pH of 5 (Weng et al. 2004). However, certain compounds can activate ASICs 
directly (Osmakov et al. 2017). Therefore, to determine whether activation of ASICs could 
underlie T. crass. homogenate induced depolarization we used the non-specific ASIC blocker 
amiloride (2 mM). The presence of amiloride did not significantly attenuate the effect of the 
homogenate (Figure 3.4 C), with the mean T. crass.  homogenate induced depolarization 
being 14.55 mV (SEM 1.41 mV) during baseline, 12.12 mV (SEM 2.25 mV) in the presence of 
amiloride and 17.06 mV (SEM 2.20 mV) following washout (N = 10, p > 0.05, repeated 
measures ANOVA, Figure 3.4 C, D).   
A further possible candidate for our excitatory small molecule was Substance P, an abundant 
neuropeptide and neurotransmitter (Liu et al. 2002; Harrison and Geppetti 2001). Robinson et 
al (2012) have found Substance P in close vicinity to human NCC granulomas. Garza et al. 
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(2010) found that Substance P signalling contributes to granuloma formation and Substance P 
enhanced NMDA channel function (Lieberman and Mody 1998). We therefore investigated 
whether Substance P could elicit a similar neuronal depolarizing response to that of T. crass. 
homogenate. However, we found that 100 µM Substance P had no acute effect on the 
membrane potential of CA3 hippocampal pyramidal neurons (0.08 mV, IQR 0.01 – 0.12 mV, 
N = 5, p > 0.05, Wilcoxon signed rank test with theoretical median = 0.00, Figure 3.4 E, F). 
Together this data indicates that T. crass. homogenate induced neuronal depolarization is not 
mediated by nicotinic acetylcholine receptors, ASIC receptors, nor Substance P. 
 
 THE DEPOLARIZING EFFECTS OF TAENIA CRASSICEPS ARE MEDIATED BY 
GLUTAMATE RECEPTOR ACTIVATION. 
The predominant excitatory neurotransmitter in the nervous system is glutamate (Bear, 
Connors, and Paradiso 2007). Glutamate activates a number of ionotropic glutamate 
receptors (GluRs) including AMPA, Kainate and NMDA receptors (Bear, Connors, and 
Paradiso 2007), therefore it is likely that T. crass. homogenate could cause neuronal 
depolarization by activation of GluRs. To test this possibility we again made whole-cell current 
clamp recordings from CA3 hippocampal pyramidal cells using a caesium based internal in 
the presence of TTX to block voltage-gated sodium channels. T. crass. homogenate induced 
neuronal depolarization was measured before, during and after the application of 10µM 
CNQX, 50µM D-AP5 and 2mM kynurenic acid to block all three classes of GluRs. I found that 
GluR blockade significantly reduced the mean T. crass. homogenate induced neuronal 
depolarization from 14.72 mV (IQR 13.39 - 15.68 mV) to 1.90 mV (IQR 1.09 - 2.21 mV, N = 9, 
p ≤ 0.01, Friedman test with Dunn’s multiple comparison test, Figure 3.5 A, B), which 
recovered to a median value of 14.37 mV (IQR 7.32 - 16.38 mV) following washout (N = 9, 
p ≤ 0.01, Friedman test with Dunn’s multiple comparison test, Figure 3.5 A, B). This indicated 
that activation of GluRs is the primary mediator of the depolarizing effect of T. crass. 
homogenate I observed. 
 
 TAENIA CRASSICEPS AND TAENIA SOLIUM LARVAE CONTAIN AND PRODUCE 
GLUTAMATE. 
Glutamate is the major excitatory neurotransmitter in the brain and the prototypical agonist of 
GluRs (Bear, Connors, and Paradiso 2007). Together with a fellow doctoral student in the lab,  







Figure 3.4 Taenia crassiceps homogenate induced neuronal depolarization is not mediated by nicotinic 
acetylcholine receptors, ASIC receptors, or Substance P. 
Whole-cell patch recordings were made from CA3 pyramidal neurons in rat organotypic hippocampal slice 
cultures using a caesium based internal in the presence of 2 μM TTX. If necessary, current was injected to 
maintain the membrane potential within 2 mV of -60 mV. A) The depolarizing response to a T. crassiceps 
homogenate (T. crass. hom.) puff (orange arrow) before (black trace), during (blue trace) and after (grey trace) 
the addition of a nicotinic acetylcholine receptor (nAchR) blocker (mecamylamine hydrochloride, 10µM). B) 
Population data demonstrating that nAchR blockade has no significant effect on the T. crass. homogenate 
induced depolarization. C) The depolarizing response to a T. crass. homogenate puff (orange arrow) before (black 
trace), during (blue trace) and after (grey trace) the addition of an ASIC receptor blocker (amiloride, 2 mM) D) 
Population data demonstrating that ASIC receptor blockade has no significant effect on the T. crass. homogenate 
induced depolarization. E)  Current clamp trace showing that a puff of 100 µM Substance P (blue arrow) does not 
affect the membrane potential of CA3 pyramidal neurons. F) Population data for Substance P application. ns = 












Figure 3.5 The depolarizing effects of Taenia crassiceps are mediated by glutamate receptor activation. 
A) Whole-cell current clamp recording from a rat CA3 pyramidal neuron in a hippocampal organotypic slice 
culture. Neuronal membrane potential in response to a 20 ms puff of T. crassiceps homogenate (T. crass. hom.)  
(orange arrow) before (black trace), during (blue trace) and following wash out (grey trace) of a pharmacological 
cocktail to block glutamate receptors (10µM CNQX, 50µM D-AP5 and 2mM kynurenic acid). B) Population data 
shows that the depolarization response to T. crass. homogenate is significantly reduced in the presence of 
glutamate receptor blockers and returns upon wash out. Values with means ± SEM; ***p ≤ 0.001, each data point 






Figure 3.6 Taenia crassiceps and Taenia solium larvae contain and produce glutamate. 
A) Glutamate levels in whole cyst homogenate of T. crassiceps (T. crass) and T. solium larvae. B) Glutamate 
production per day per 15 larvae for 6 days in vitro for T. crass. and T. solium larvae. Note that both species of 
larvae produce glutamate de novo, particularly on days 4 – 6. 
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Anja de Lange, we directly measured the concentration of glutamate in the T. crass. 
homogenate we had been puffing onto neurons using a glutamate assay (see Materials and 
Methods page 24). We found that the mean concentration of glutamate in the T. crass. 
homogenate was 6.47 μg/mg (SEM 0.97 μg/mg, N = 5, Figure 3.6 A) – corresponding to 
approximately 112 μM for puffing experiments. Glutamate at this concentration robustly 
activates GluRs in hippocampal pyramidal neurons (Forman et al., 2017). T. crass., whilst a 
closely related species to T. solium, is not the causative pathogen in humans. We therefore 
also measured the glutamate concentration in homogenate prepared from larvae of T. solium, 
the predominant pathogen responsible for human NCC. We recorded a glutamate 
concentration of 4.56 μg/mg (N = 1), which indicates that the concentration of this excitatory 
neurotransmitter is also high within larvae of T. solium (Figure 3.6 A).  
Whilst glutamate is a neurotransmitter in the CNS, it is also an ubiquitous metabolite present 
in the cytoplasm of the majority of cells (Newsholme et al. 2002). Therefore it is possible that 
the T. crass. and T. solium homogenate only contains glutamate due to cell lysis during 
homogenate preparation. To determine whether larvae of both these cestodes actively 
produce and excrete or secrete glutamate into their environments we measured the de novo 
daily production of glutamate by larvae following harvest of live larvae from the intermediate 
host (mice for T. crass. and pigs for T. solium , see Materials and Methods page 24). Both 
species of larvae were observed to generate glutamate de novo and release this into the 
culture media (Figure 3.6 B). T. crass. larvae released a relatively constant daily amount of 
glutamate (mean 64.07 μg/15 larvae per day, SEM 4.31 μg/15 larvae per day, N = 3, Figure 
3.6 B). T. solium larvae released a large amount of glutamate on the first day post-harvest, 
none on the 2nd and 3rd day in vitro, but again begin to produce large amounts of glutamate on 
days 4, 5 and 6 (mean 137.06 μg/15 larvae per day, SEM 58.49 μg/15 larvae per day, N = 1, 
Figure 3.6 B).  Collectively these results demonstrate that larvae of both T. crass. and T. solium 
contain and release glutamate into their immediate surroundings. 
  
 DISCUSSION 
In this chapter I investigated the acute effects of T. crass. larval homogenate on pyramidal 
neurons in the CA3 region of the hippocampus in cultured organotypic rodent brain slices. To 
do this I performed patch-clamp recordings of neuronal voltage whilst applying puffs of 
tapeworm homogenate onto the cells. 
In the first experiment I showed that, indeed, T. crass. homogenate is able to depolarise the 
membrane voltage of a cell, and that the more homogenate that is applied, the more excitable 
the cell became, producing multiple action potentials. The mechanical effect of the puffs from 
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the OpenSpritzer were controlled for by applying aCSF onto cells, with no measurable 
response. Furthermore we were able to show, with the use of calcium imaging, that excitation 
from an application of T. crass. was able to propagate to neurons out of the proximity of the 
puff of homogenate, and was even able to generate epileptiform activity. 
Next I measured the ionic components of the larval homogenate and found the K+ 
concentration to be somewhat raised compared with that found extracellularly in the CSF 
(11.39 mM). This was somewhat expected as the homogenate was made by lysing the larvae, 
and given that the typical concentration of K+ within cells is very high (±100 mM) one might 
have expected a much higher K+ concentration of the homogenate. The comparatively low 
homogenate K+ concentration suggests that the larval cystic fluid must make up a large 
proportion of the total larval fluid, and that this cystic fluid has a relatively low K+ concentration. 
Never-the-less, the slightly raised concentration of K+ in the homogenate, when applied 
extracellularly to neurons, is predicted to reduce the flow of K+ ions out of the neuron, resulting 
in more positive charge remaining inside and thus raising the membrane voltage closer to the 
spike threshold. Indeed, when a solution of aCSF with the equivalent concentration of K+ 
(11.39 mM) to the homogenate was puffed onto neurons it resulted in a modest (approximately 
2 mV) increase in membrane voltage. This therefore likely contributed to, but did not 
completely account for, the marked depolarising effect that the larval homogenate has on 
neurons. Wang et al. (2016) have noted that when the aCSF extracellular K+ is raised to 9 mM 
it can have significant pro-seizure effects (greater seizure duration, shortened interictal 
intervals etc.) but that at concentrations higher than this neurons went into depolarisation-
block. Our model is unlikely to show such a strong effect as we were only altering the 
extracellular K+ concentration in a localised position, by puffing the high K+ aCSF onto our 
recording cell. In order to exclude the depolarizing contribution of raised K+ within the 
homogenate, a caesium internal solution was used for the remaining experiments in the 
chapter to block the K+ channels and thus exclude this effect. 
Thereafter I separated the homogenate by size using a 3 kDa membrane and found that once 
all molecules smaller than 3 kDa had dialysed out of the homogenate it no longer had a 
depolarising effect on the neuronal membrane potential. I then wanted to identify which small 
molecule was having the excitatory effect or at least which neurotransmitter system it was 
having an effect on. To do this I performed a series of experiments utilising blockers of 
acetylcholine (mecamylamine hydrochloride) or ASICs (amiloride) and by applying Substance 
P directly to compare the effect. None of these neurotransmitter systems explained the 
T. crass. effect. I then utilised a cocktail of glutamate blockers (kynurenic acid, CNQX and 
D-AP5) which were successful in abolishing the excitatory response. I could therefore 
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conclude that the larval homogenate was generating its effect by binding to glutamate 
receptors. 
In order to ascertain whether the larval homogenate contained glutamate itself or a glutamate 
agonist my colleague, Anja de Lange, performed assays to determine the amount of glutamate 
in the homogenate of T. crass. and T. solium, as well as the amount of glutamate produced 
by viable T. crass. and T. solium larvae. This is the first time, to my knowledge, that it has 
been conclusively known that T.crass. and T. solium larvae both produce and contain 
glutamate, which is able to depolarise pyramidal neurons and even cause epileptiform-type 
activity. 
The limitation is that only the most acute response is investigated using these methods. 
Glutamate, being the main excitatory transmitter in the brain, is very tightly buffered by 
neurons and astrocytes and so the additional extracellular glutamate may be quickly removed 
in a less acute model. Thus in chapter 4 I investigated how 24 hour treatment of organotypic 
mouse brain slices with T. crass. homogenate affected the intrinsic properties of neurons and 





4 THE SHORT-TERM EFFECTS OF TAENIA CRASSICEPS 
ON NEURONS IN VITRO 
 INTRODUCTION 
In the previous chapter I explored the acute, very immediate (i.e. millisecond to second) effects 
of T. crass. larval products on neurons, which would reflect direct effects on receptors and ion 
channels. To explore potential longer-term effects driven by processes which might require 
longer time scales (i.e. second messenger cascades, phosphorylation, innate immunity or 
gene expression) I treated organotypic brain slices for 24 hours with T. crass. larval 
homogenate.  
Inflammatory markers have been found in the brains of patients with NCC (Restrepo et al. 
2001; Sheng et al. 1994), and have been shown to be released by glia in the presence of 
tapeworm homogenate within hours, usually peaking by 24 hours (Uddin et al. 2005). 
Inflammation also impairs glutamate buffering by astrocytes (Van Vliet et al. 2007; Seiffert et 
al. 2004). In turn, a build-up of glutamate can enhance neuronal excitability. Therefore, the 
addition of an external source of glutamate such as from T. crass. or T. solium 
larvae/homogenate (the finding from Chapter 3) could possibly change the intrinsic properties 
of neurons (Hamlet and Lu 2016) or the excitability of the network (DeLorenzo, Pal, and 
Sombati 1998). Beyond this, it is also possible that hitherto unidentified factors within the 
T. crass. larval homogenate could modify the properties of neuronal circuits within brain slices 
on a longer timescale than that explored in the previous chapter.  
Thus I treated brain slices with tapeworm homogenate for 24 hours. Beside the negative 
control of standard growth media I also included a “positive control” group treated with 
lipopolysaccharide (LPS). LPS is a component of the cell wall of gram negative bacteria and 
is strongly pro-inflammatory through its activation of microglial Toll-like Receptors (Lively and 
Schlichter 2018) and the subsequent release of cytokines such as IL-1β, TNF- α and IL-6 
(Papageorgiou et al. 2016). Furthermore, LPS treatment has been shown to exert 
electrophysiological changes on hippocampal neurons in vitro (Hellstrom et al. 2005). I utilised 
whole-cell patch-clamp recordings of pyramidal cells in mouse hippocampal sections to 
investigate possible differences in neuronal firing properties, ion currents and seizure 
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threshold. I found that 24 hours of T. crass. homogenate exposure had no effect on the 
membrane properties, active firing properties, sodium or potassium currents of neurons nor 
on network excitability. In contrast LPS exposure did increase the spiking threshold of 
neurons.  
 
 SUSTAINED EXPOSURE TO TAENIA CRASSICEPS HOMOGENATE DOES NOT 
AFFECT BASIC NEURONAL MEMBRANE PROPERTIES.  
Mouse hippocampal organotypic brain slice cultures were prepared and maintained with 
standard growth media until day 6 or 7 when they were treated for 24 hours with either; 
standard growth media or media containing T. crass. homogenate (50 µg/ml) or LPS 
(10 µg/ml). Whole-cell patch-clamp recordings were then made from hippocampal pyramidal 
neurons and used to assess how the various treatment conditions might have affected the 
intrinsic properties of the neurons (Figure 4.1 A). Standard growth media was used as a 
negative control. LPS was used as a potential positive control in order to drive an innate 
inflammatory response in the slices. Sun et al. (2014) found high concentrations of cytokines 
produced by microglia in response to a 24 hour treatment with helminth soluble factors. Since 
this timeframe was enough to evoke an immune response, we wondered whether we might 
also see electrophysiological changes during this same time period. 
The quality of each patch was determined by calculating the access resistance (Ra), which 
determines how effective the electrical access (conductance) is to the cell. Only cells with a 
Ra under 30 mOhm were chosen to ensure optimal recordings were achieved. The mean Ra 
for the T. crass., LPS and media groups were 17.18 mOhm (SEM 1.66 mOhm, N = 14), 
18.54 mOhm (SEM 1.53 mOhm, N = 9) and 13.66 mOhm (SEM 1.05 mOhm, N = 11), 
respectively and were not significantly different from one another (p > 0.05, One-way ANOVA, 
data not shown in figure). This ensured that recording conditions were equivalent between 
treatment groups. 
Thereafter I first measured the resting membrane potential, membrane resistance and 
capacitance, which comprise the basic membrane properties and fundamentally modulate 
neuronal signalling. Resting membrane potential is the measurement of the voltage across 
the membrane under baseline conditions. An alteration in this intrinsic property could result in 
a more excitable neuron. The mean resting membrane potential for the T. crass., LPS and 
media groups were -64.72 mV (SEM 5.88 mV, N = 14), -61.82 mV (SEM 8.26 mV, N = 9) and 
-64.43 mV (SEM 3.96 mV, N = 11), respectively and were not significantly different from one 
another (p > 0.05, One-way ANOVA, Figure 4.1 B). 
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Membrane resistance reflects how easily ions can flow through the cell membrane and thus 
is an indicator of the number of ion channels, particularly K+ leak channels in the neuronal 
membrane. The mean membrane resistance for the T. crass., LPS and media groups were 
200.30 mOhm (SEM 95.99 mOhm, N = 15), 185.30 mOhm (SEM 89.70 mOhm, N = 10) and 
193.30 mOhm (SEM 61.79 mOhm, N = 12), respectively and were not significantly different 
from one another (p > 0.05, One-way ANOVA, Figure 4.1 C). 
Membrane capacitance represents the size of the lipid membrane and the charge it is able to 
store across it. It also determines how quickly a cell’s membrane potential can respond to a 
change in current. The median capacitance for the T. crass., LPS and media groups were 
182.2 mµF (IQR 131.9 – 250.0 mµF, N = 14), 169.4 mµF (IQR 163.1 – 220.5 mµF, N = 9) and 
186.8 mµF (IQR 174.2 – 249.6 mµF, N = 11), respectively and were not significantly different 
from one another (p > 0.05, Kruskal-Wallis test, Figure 4.1 D).  
Together the membrane resistance and membrane capacitance determine the membrane 
time constant which sets the integrative properties of a neuron. My data showed that slice 
incubation for 24 hrs with neither T. crass. homogenate nor LPS had any significant effect on 
the basic membrane properties of hippocampal pyramidal cells. 
 
 SUSTAINED EXPOSURE TO TAENIA CRASSICEPS HOMOGENATE DOES NOT 
AFFECT THE ACTIVE FIRING PROPERTIES OF NEURONS. 
The intrinsic excitability of a neuron is largely determined by how readily and at what rate it 
can generate action potentials. Changes in the active firing properties of neurons have been 
demonstrated in a number of epilepsy syndromes (Avanzini and Franceschetti 2003). 
Therefore to determine whether longer-term exposure of T. crass. homogenate affected the 
active firing properties of neurons I measured; spike threshold, current threshold density, 
maximum spike rate, absolute maximum spike rate, current and current threshold density 
which evoke the maximum spike rate in neurons in the same three treatment conditions. 
I first calculated the spike threshold by performing a series of current steps, which increased 
the membrane voltage until the first action potential was generated. The spike threshold was 
determined as the voltage at which the first action potential was generated (Figure 4.2.1 A). 
The spike threshold essentially shows how excitable a cell is as a more negative spike 
threshold would mean that relatively little depolarising synaptic input is required for that cell to 
spike. The median spike threshold for each of the T. crass., LPS and media groups 
were -34.13 mV (IQR -34.99 – -32.74 mV, N = 14), -31.55 mV (IQR -32.76 – -30.60 mV, N = 9) 
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and -33.64 mV (IQR -34.12 – -33.04 mV, N = 11). No difference was seen between T. crass. 







Figure 4.1 Sustained exposure to Taenia crassiceps homogenate does not affect neuronal membrane 
properties. 
A) Whole–cell patch-clamp recordings were made from CA3 pyramidal neurons in mouse hippocampal 
organotypic slice cultures. Slices were treated for 24 hours pre-electrophysiological recording with either; 50 µg/ml 
Taenia crassiceps homogenate, 10 µg/ml LPS or standard growth media. B) There was no significant difference 
between any of the groups for the resting membrane potential of the cells. C) The membrane resistance also did 
not differ significantly between groups. D) There was no significant difference in the capacitance between any of 
the groups. Values with means ± SEM; ns = not significant, each data point represents a recording from one cell.  
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spike threshold than the T. crass. group (p = 0.0098, Kruskal-Wallis test with Dunn’s multiple 
comparison test, Figure 4.2.1 B) meaning LPS treatment makes cells less excitable. 
Current threshold density is the amount of current a cell requires to fire its first action potential 
normalised by the cell’s capacitance, which accounts for the size of the cell and is a more 
finely tuned way of measuring excitability. The median current threshold density for each of 
the T. crass., LPS and media groups were 0.74 pA/pF (IQR 0.55 – 1.19 pA/pF, N = 14), 
0.85 pA/pF (IQR 0.48 – 1.07 pA/pF, N = 9) and 0.85 pA/pF (IQR 0.45 – 0.98 pA/pF, N = 11), 
respectively and were not significantly different from one another (p > 0.05, Kruskal-Wallis 
test, Figure 4.2.1 C). 
The maximum spike rate is a metric of how rapidly a cell can send signals by measuring the 
maximum number of action potentials it can generate in a given time. The maximum spike 
rate is calculated using a series of current steps, which increase the membrane voltage such 
that a cell is generating as many action potentials as possible (Figure 4.2.2 A). The number is 
counted for the first 500 ms of the current step recording thus resulting in a spike rate denoted 
in Hz. The maximum spike rate for each of the T. crass., LPS and media groups were 23.00 Hz 
(SEM 1.24 Hz, N = 14), 19.33 Hz (SEM 2.11 Hz, N = 9) and 22.36 Hz (SEM ± 1.23 Hz, N = 11), 
respectively and were not significantly different from one another (p > 0.05, One-way ANOVA, 
Figure 4.2.2 B). 
The absolute maximum spike rate was calculated as the shortest time between spikes and 
shows the absolute fastest a cell could send signals, theoretically as it would be unlikely to 
sustain this speed. The median absolute maximum spike rate for each of the T. crass., LPS 
and media groups were 41.45 Hz (IQR 34.71 – 51.62 Hz, N = 14), 40.00 Hz (IQR 32.80 - 
55.62 Hz, N = 9) and 45.98 Hz (IQR 40.40 – 63.49, Hz, N = 11), respectively and were not 
significantly different from one another (p > 0.05, Kruskal-Wallis test, Figure 4.2.2 C). 
Since I did not observe any differences between the T. crass. and control groups in terms of 
their active firing properties I next wanted to ensure I wasn’t missing a potential difference 
whereby cells could achieve the same maximum spike rate but might require different amounts 
of input current to do so. I therefore calculated the mean current which evokes the maximum 
spike rate for each of the T. crass., LPS and media groups, which were 637.40 pA (SEM 90.08 
pA, N = 14), 535.80 pA (SEM 92.54 pA, N = 9) and 753.20 pA (SEM 99.50 pA, N = 11), 
respectively and were not significantly different from one another (p > 0.05, One-way ANOVA, 
Figure 4.2.2 D). Performing the same analysis but normalising for cell size; the mean current 
threshold density which evokes the maximum spike rate for each of the T. crass., LPS and 
media groups were 3.29 pA/pF (SEM 0.31 pA/pF, N = 14), 2.98 pA/pF (SEM 0.48 pA/pF,   




4.2.1 Sustained exposure to Taenia crassiceps homogenate does not affect the active firing properties 
of neurons; including the spike threshold and current threshold density. 
Whole–cell patch-clamp recordings were made from CA3 pyramidal neurons in mouse hippocampal organotypic 
slice cultures. Slices were treated for 24 hours pre-electrophysiological recording with either; 50 µg/ml Taenia 
crassiceps homogenate, 10 µg/ml LPS or standard growth media. A) Example trace showing the current required 
to raise the membrane voltage high enough for the cell to fire an action potential, with the pink line indicating the 
spike threshold or the voltage at which the first action potential is fired. B) The spike threshold significantly differs 
only between the Taenia crassiceps and LPS groups. C) There were no differences between the any of the groups 
for the current threshold density. Values with means ± SEM; **p < 0.01, ns = not significant, each data point 
represents a cell. 




4.2.2 Sustained exposure to Taenia crassiceps homogenate does not affect the active firing properties of 
neurons; including the maximum spike rate and its relationship to current threshold density. 
Whole–cell patch-clamp recordings were made from CA3 pyramidal neurons in mouse hippocampal organotypic 
slice cultures. Slices were treated for 24 hours pre-electrophysiological recording with either; 50 µg/ml Taenia 
crassiceps homogenate, 10 µg/ml LPS or standard growth media. A) Example trace showing the maximum 
number of spikes that can be elicited from a cell in order to determine the max spike rate and absolute max spike 
rate for each of the experimental conditions. B & C) Neither the maximum spike rate nor the absolute maximum 
spike rate differed significantly between the groups. D & E) Both the current and the current threshold density 
required to evoke the max spike rate also did not differ significantly between the groups. F) Furthermore, the 
relationship between the firing frequency and current threshold density did not differ between the groups. Values 
with means ± SEM; ns = not significant, each data point represents a cell. 
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N = 9) and 3.46 pA/pF (SEM 0.26 pA/pF, N = 11), respectively and were not significantly 
different from one another (p > 0.05, One-way ANOVA, Figure 4.2.2 E).     
I then wondered if perhaps a difference would exist below the level of the maximum spike rate 
and so analysed the firing frequency at increasing current threshold densities. The relationship 
between the firing frequency and current density did not differ significantly between the groups 
(p > 0.05, Friedman test, Figure 4.2.2 F). Although it was not statistically significant, for the 
above metrics of active firing properties, the LPS condition tended to be slightly less excitable. 
The T. crass. condition however, was almost indistinguishable from the control group, which 
demonstrated that 24 hrs of T. crass. homogenate application had no observable effect on the 
active firing properties of hippocampal pyramidal neurons.   
 
 SUSTAINED EXPOSURE TO TAENIA CRASSICEPS HOMOGENATE DOES NOT 
AFFECT THE SIZE OF VOLTAGE-GATED SODIUM CURRENTS IN NEURONS. 
Ion flux across the membrane determines changes in membrane voltage. Na+ flux through 
voltage-gated Na+ channels underlies the membrane depolarization, which constitutes the 
neuronal action potential. An example trace in voltage clamp demonstrates the Na+ current 
that is generated when voltage-gated Na+ channels are opened following a voltage step to a 
more positive potential (10 mV) (Figure 4.3 A). 
The mean absolute maximum voltage-gated Na+ current for each of the T. crass., LPS and 
media groups were -5573 pA (SEM 455.3 pA, N = 14), -4732 pA (SEM 467.7 pA, N = 9) and 
-6202 pA (SEM 337.7 pA, N = 11), although there was a trend for the size of currents in the  
LPS treated condition to be smaller, there was no significant difference between any of the 
conditions (p > 0.05, One-way ANOVA, Figure 4.3 B). 
 
 SUSTAINED EXPOSURE TO TAENIA CRASSICEPS HOMOGENATE DOES NOT 
AFFECT THE MAXIMUM SIZE OF POTASSIUM CURRENTS IN NEURONS. 
The movement of K+ out of the cell is responsible for the repolarisation of the membrane and 
is also essential to a cell’s ability to send signals rapidly. An example trace in the voltage clamp 
recording configuration demonstrates the current generated when K+ channels are open at a 
depolarised potential (30 mV) (Figure 4.4 A). 
The median maximum K+ current for each of the T. crass., LPS and media groups were 2947 
pA (IQR 2382 – 4483 pA, N = 11), 2500 pA (IQR 2068 - 3682 pA, N = 8) and 4338 pA (IQR 
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2633 - 4626 pA, N = 9), respectively and were not significantly different from one another (p > 




4.3 Sustained exposure to Taenia crassiceps homogenate does not affect the maximum size of 
voltage-gated sodium currents in neurons. 
Whole–cell patch-clamp recordings in voltage clamp mode were made from CA3 pyramidal neurons in mouse 
organotypic slice cultures. Slices were treated for 24 hours pre-electrophysiological recording with either; 50 µg/ml 
Taenia crassiceps homogenate, 10 µg/ml LPS or standard growth media. A) Example trace showing the 
measurement of the absolute maximum voltage-gated sodium current elicited following positive voltage steps. B) 
The mean maximum sodium current was not significantly different between the groups. Values with means ± 
SEM; ns = not significant, each data point represents a cell. 
 






4.4 Sustained exposure to Taenia crassiceps homogenate does not affect the maximum size of 
potassium currents in neurons. 
Whole–cell patch-clamp recordings in voltage clamp mode were made from CA3 pyramidal neurons in mouse 
hippocampal organotypic slice cultures. Slices were treated for 24 hours pre-electrophysiological recording with 
either; 50 µg/ml Taenia crassiceps homogenate, 10 µg/ml LPS or standard growth media. A) Example trace 
showing the measurement of the maximum K+ current in voltage clamp following a positive voltage step to 30 mV. 
B) The mean maximum K+ current was not significantly different between the groups. Values with means ± SEM; 
ns = not significant, each data point represents a cell. 
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 SUSTAINED EXPOSURE TO TAENIA CRASSICEPS HOMOGENATE DOES NOT 
AFFECT THE EXCITABILITY OF THE NEURONAL NETWORK. 
In order to understand if treatment with T. crass. makes the neuronal network more excitable 
I used the well-established 0 Mg2+ model to investigate how quickly the network would enter 
epileptiform states given this excitatory stimulus. I compared the time to first seizure-like event 
(SLE) as well as the power spectral density for each recording.  
Seizure-like events could be identified by large depolarizations of the neuronal membrane 
potential with rapid firing of action-potentials lasting more than five seconds. SLEs were also 
observable as large increases in signal power (4.5 A).  
The median power in the frequency range (1-100 Hz) from the start of recording for each of 
the T. crass., LPS and media groups were 0.018 mV2/Hz (IQR 0.005 – 0.115 mV2/Hz, N = 12), 
0.011 mV2/Hz (IQR 0.005 – 0.025 mV2/Hz, N = 6) and 0.027 mV2/Hz (IQR 0.019 – 
0.065 mV2/Hz, N = 11), respectively and were not significantly different from one another 
(p > 0.05, Kruskal-Wallis test, 4.5 B). 
The median power from the start of the first SLE for each of the T. crass., LPS and media 
groups were 0.031 mV2/Hz (IQR 0.011 – 0.210 mV2/Hz, N = 12), 0.069 mV2/Hz (IQR 0.028 – 
0.252 mV2/Hz, N = 6) and 0.069 mV2/Hz (IQR 0.052 – 0.179 mV2/Hz, N = 11), respectively 
and again were not significantly different from one another (p = 0.50, Kruskal-Wallis test, 
4.5 C). 
The median time from the start of 0 Mg2+ wash in to the first SLE for each of the T. crass., LPS 
and media groups were 354.2 s (IQR 316.4 – 580.6 sec, N = 12), 396.3 s (IQR 359.7 – 553.8 
sec, N = 7) and 354.6 s (IQR 335.5 – 378.7 sec, N = 11), respectively.  No significant difference 
was observable between the groups (p > 0.05, Kruskal-Wallis test, 4.5 D).  






4.5 Sustained exposure to Taenia crassiceps homogenate does not affect the excitability of the 
neuronal network. 
Whole–cell patch-clamp recordings were made from CA3 pyramidal neurons in mouse hippocampal organotypic 
slice cultures. Slices were treated for 24 hours pre-electrophysiological recording with either; 50 µg/ml Taenia 
crassiceps homogenate, 10 µg/ml LPS or standard growth media. A) The 0 Mg2+ model was then used to elicit 
seizure-like activity. Top, neuronal membrane potential following wash in of the 0 Mg2+ solution. Bottom, 
spectrogram indicating the signal power at each frequency. B & C) Neither the mean power (1-100 Hz) from the 
start nor the mean power from the first SLE were significantly different between the groups. D) The time to first 
SLE was also not significantly different between the groups. Values with means ± SEM; ns = not significant each 
data point represents a cell. 
 
  




In Chapter 3 I described the discovery that T. crass. (and T. solium) larvae contain and actively 
produce glutamate, which is the mechanism by which the larval homogenate is able to have 
a depolarising effect on neurons, with the potential to evoke epileptiform activity under the 
correct conditions. However, that set of experiments only explored the very acute effects (ms 
to s) of larval homogenate, without being able to probe effects on longer-term processes, such 
as innate immunity, gene expression or second messenger cascades. Therefore in the current 
chapter I investigated possible longer term effects on neuronal intrinsic properties and network 
excitability elicited by 24 hour application of T. crass. homogenate and also compared this to 
LPS application, a known inflammatory stimulant.   
My overriding, and perhaps surprising finding, was that for all of the many metrics tested, I 
found no detectable difference between T. crass. homogenate treated and control brain slices. 
That is, 24 hours of exposure to T. crass. homogenate drove no differences in neuronal 
membrane properties, active firing properties nor overall network excitability. Potential 
changes could either have been driven by the glutamate in the homogenate (as identified in 
Chapter 3) or by some hitherto unidentified factor. Given that I observed no changes, it is 
worth considering why the glutamate in the homogenate appeared to drive no changes in the 
slices. Using our glutamate measurements of the T. crass. homogenate taken in Chapter 3 I 
calculated that treating the slices with T. crass. homogenate at a concentration of 50 µg protein 
/ ml equated to a final concentration in the media of 3 µM of glutamate. This is ultimately not 
a particularly high extracellular glutamate concentration as the concentration of glutamate in 
normal cerebrospinal fluid is 10 µM (Moussawi et al. 2011) and estimates of brain physiological 
extracellular glutamate concentration range from 0.02 to 30 μM (Herman and Jahr 2007; 
Chefer et al. 2015). In addition, it is quite possible that glutamate uptake mechanisms by 
neurons and glia would have further reduced the extracellular concentration of T. crass. 
derived glutamate (i.e. below the initial 3 µM) (Moussawi et al. 2011). At this low concentration 
of glutamate (< 3 µM), it is perhaps unsurprising that we did not see any evidence of changes 
in intrinsic properties or network excitability as these typically require extended exposure to 
much higher concentrations of glutamate (Ziobro, Deshpande, and DeLorenzo 2011). 
Given that glutamate in the T. crass. homogenate at the concentrations used was unlikely to 
drive changes in excitability it is therefore interesting to note that other potential factors in the 
homogenate also did not drive any changes in intrinsic properties or network excitability.  
There are several potentials reasons for this. Firstly, it is possible that the concentration of 
T. crass. homogenate was too low (50 µg protein / ml). I was unable to increase this further 
without significantly modifying the composition of the media. At the concentration used, the 
T. crass. homogenate consisted of approximately 5 % of the total volume of media. 
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Nonetheless larval derived secreted factors or homogenate at concentrations well below 50 
µg protein / ml have been shown to modulate inflammatory signalling (Palma et al. 2019; Y. 
Sun et al. 2014; Emilia Vendelova et al. 2016; Amit et al. 2011; Prasad et al. 2009). Therefore 
if factors within the T. crass. homogenate were to stimulate neurons either directly or via 
modulating inflammatory signalling, we would expect this to occur at the concentration utilised. 
As a result we can conclude that T. crass. homogenate exposure does not drive changes in 
neuronal excitability over a 24 hour timescale. Future work could expose brain slices to 
T. crass. larval product for longer than 24 hours. To my knowledge no studies have looked at 
the functional properties of cells following exposure to T. crass., so there are no comparisons 
to draw as of yet in terms of the optimal length of exposure to begin to alter neuronal 
properties.  
It has long been suggested that neuroinflammation plays a key role in the epileptogenic 
process (Vezzani et al. 2011). LPS is a potent and prototypical inflammatory stimulant which 
is known to cause classical activation of microglia and the release of inflammatory cytokines 
(Lively and Schlichter 2018; Papageorgiou et al. 2016). It was thus surprising that our intended 
positive control consisting of 24 hrs of LPS application did not drive particularly strong changes 
in neuronal intrinsic properties or network excitability. However, I did observe that LPS 
increased the action potential threshold in the neurons, making them less excitable. In many 
of the other metrics, despite not reaching the p < 0.05 threshold, the general trend of LPS 
exposure was to reduce the excitability of neurons and the network. It was therefore surprising 
to observe that this potent inflammatory stimulant, was having a mild inhibitory effect. 
However, this finding is consistent with the literature. For example, Hellstrom et al. (2005), 
found that one week exposure of organotypic hippocampal brain slices with 100 ng/ml of LPS 
also increased the action potential threshold of neurons and reduced excitability.  
It is also worth noting the T. crass. homogenate did not result in the same moderate changes 
as LPS, which suggests that perhaps the homogenate used did not drive an inflammatory 
response in the same way as LPS, although this would be better assessed by measuring 
cytokine release or changes in microglial morphology.  
It is also possible that we saw no changes due to the “type” or “state” of the T. crass. larvae 
prior to homogenization. It is known that whilst Taenia larvae are viable / alive within the brain, 
patients are typically asymptomatic (Stringer et al. 2003; Y. Sun et al. 2014), and that it is only 
once the larvae die naturally, or are killed using anti-helminthic agents that the likelihood of 
seizures occurring increases (Verma et al. 2010; Nash, Pretell, and Garcia 2002). In my 
experiments, T. crass. homogenate was prepared from live, viable larvae which were first 
freeze-thawed to lyse the cells before homogenization. Perhaps, a factor that could possibly 
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increase neuronal excitability is only present in dead or dying larvae. Future work could use 
T. crass. homogenate where the larvae are either starved or treated with anti-helminthic 
agents to see if this might contain additional factors, which could modulate neuronal excitability 
in this paradigm.  
Lastly, the organotypic brain slice model, whilst containing all resident brain cells including 
microglia, lacks cells of the adaptive immune response such as T helper type 1 cells and/or 
natural killer cells. It is possible that for T. crass. homogenate to evoke seizures, a fully 
integrated immune response and/or blood brain barrier disruption is required. It is also possible 
that longer exposure to the T. crass. homogenate (longer than 24 hours) is required in order 
to generate an effect either mediated by immune signalling or otherwise. To address these 
issues, in the following chapter I set out to establish an in vivo model of NCC, whereby 
T. crass. homogenate was repeatedly injected into the cortex and hippocampus of freely 





5 THE CHRONIC EFFECTS OF TAENIA CRASSICEPS ON 
NEURONS IN VIVO 
 INTRODUCTION 
In Chapter 3 I observed that T. crass. had an acute excitatory effect on neurons mediated by 
glutamatergic signalling. However, in Chapter 4, a 24 hour exposure to T. crass. homogenate 
in vitro, did not alter the excitability of individual neurons nor the network. Whilst the 
organotypic brain slice culture model retains innate immune cells such as microglia, a key 
difference between it and the human disease condition is the presence of an adaptive immune 
response. Neuroinflammation is thought to play an important role in epileptogenesis (Vezzani 
et al. 2011), therefore in this chapter  I sought to investigate whether challenging an intact 
animal with T. crass. larval product could lead to the development of seizures similar to those 
seen in human NCC. In effect I sought to create an in vivo animal model of NCC resulting in 
seizures. 
Only a handful of studies have attempted to generate  in vivo animal models of NCC, and most 
either did not track or measure seizure occurrence, the main phenotypic feature of NCC, or 
only recorded seizures for up to several hours (Stringer et al. 2003; Robinson et al. 2012), 
when in humans the disease has a time course more akin to years. One study by Verastegui 
et al. (2015) injected activated oncospheres of T. solium into rats and monitored them 
sporadically for between 4 and 6 months. In order to recapitulate the time-course of the 
disease from the moment when the tapeworm larvae die, I injected larval homogenate, rather 
than activated oncospheres. Symptoms can often take months to years to develop in people 
with NCC therefore it was important to monitor animals for possible seizure activity for a long 
enough time period. The rats used in this study were approximately 3 months of age (young 
adults) at the time of the surgery  and as such between 10.5 and 11.8 rat days would equate 
to 1 human year (Andreollo et al. 2012; Sengupta 2013). Therefore, the chosen 12 week (84 
day) experimental timeline would equate to between 7.12 and 8 human years (e.g. 84 / 11.8 
rat days = equivalent # human years) and would afford enough time to effectively model NCC 
disease progression.  




In this chapter, homogenate of T. crass. larvae were injected intradermally as well as 
intracranially and the animals were monitored continuously using wireless ECoG. This is the 
first time, to my knowledge, that such technology has been utilised in a model of NCC. In 
addition, this technique enabled the recording of a full range of ECoG representing different 
brain activity corresponding to rest, wakefulness, anaesthesia as well as seizures following 
injection of a known pro-convulsant. All the while rats were able to perform all of their normal 
behaviours in their cage unhindered. After the 12 weeks of recording, an intradermal and 3 
intracranial injections of T. crass. larval homogenate, and a seizure threshold test, the brains 
were harvested for fluorescent immunohistochemical labelling of astrocytes and microglia.  
In this chapter I found that intradermal and intracranial injections of T.crass. homogenate did 
not result in the development of seizure activity in vivo and did not affect the seizure threshold 
in these animals. Astrocytes appear to be unaffected in this model of NCC but microglial 
morphology showed some changes in response to T. crass. injection.  
 
 SETUP AND PROCEDURE FOR RECORDING ECOG IN FREELY MOVING RATS.  
To establish the method for chronic, continuous recording of ECoG in rats I utilised wireless 
telemetry which included a transmitter and receiver from Open Source Instruments (OSI). 
Electrodes placed into the brain parenchyma enabled the activity of the nearby neurons to be 
recorded, this information was sent wirelessly via a subcutaneous transmitter to a receiver coil 
near the animal’s cage. From there signals were recorded and analysed by Neuroarchiver 
software running on a laptop. The wireless nature of the system allowed for the rat to go about 
all their regular activities; eating, sleeping and grooming, and allowed for 24 hour per day 
recordings to be made. This is vital for the development of any seizure type model as the 
chance of missing a seizure would be high were the recording time limited. Seizures are 
sometimes more common during certain behavioural tasks depending on where the epileptic 
focus is in the brain, so having the technology to record wirelessly while a rat exhibits all of his 
regular behaviours was ideal.  
The OSI transmitter and battery are situated inside of a well-insulated, round container during 
fabrication that is small enough to sit comfortably within an adult rat but is also large enough 
to contain a battery that can power the transmitter for over 12 weeks (Figure 5.1 A). During 
surgery a large, subcutaneous pocket was made over the dorsum of the animals into which 
the transmitter was placed such that the transmitter coil (wire with transparent insulation) and 
body sit adjacent to the incision site, which was then well stitched (Figure 5.1 C). A 
subcutaneous tunnel was made from this pocket so that the two electrode wires (orange and 




black) burrowed up the right side of the body to the cranium where they reached an 
oval-shaped skin excision exposing the skull (Figure 5.1 C). Burr holes were drilled through 
the skull at 2 locations on contralateral sides for placement of the electrodes into the cortex of 
each recording site. The wire ends of each electrode were prepared; stripped, straightened 
and bent at a 90° angle; and then inserted through the hole in the skull into the brain. Each 
electrode was held in place by either a screw or cannula (Figure 5.1 C). A further partial burr 
hole was drilled and into it was placed the ‘fixing screw’ which helped to add stability to the 
final headpiece construction when the dental cement was added (Figure 5.1 B). 
The locations and depth of the electrodes for both hemispheres was kept consistent for all rats 
and was calculated using ‘The Rat Atlas in Stereotaxic Coordinates, 6th edition (Paxinos and 
Watson 2007). The reference electrode location was in the visual cortex (V2) above the 
hippocampus (CA1) of the left hemisphere (injections into both the hippocampus and the 
cortex for half of the rats, X: -2.60 mm, Y: -4.44 mm) and the recording electrode location was 
in the visual cortex (V1) of the right hemisphere (injection into the cortex for all rats, X: +3 mm, 
Y: -7 mm) (Figure 5.1 D, F).  
Once surgery was complete and the electrodes were fixed in place, rats were housed in a 
standard rat cage placed inside of a faraday cage, with a receiver coil to transmit the ECoG 
signals to a nearby laptop (Figure 5.1 E). ECoG was recorded 24 hours per day for the full 12 
weeks giving a reliable indication of the state of activity of the rats’ brains. 
 
 CHARACTERISATION OF RECORDED ECOG PATTERNS IN FREELY MOVING 
RATS.  
In order to validate that the recording system was working correctly I analysed some initial 
ECoG and found that I could easily characterise different waveforms based upon the activity 
of the rat. Baseline activity consisted of low amplitude but varied signals with no discernible 
pattern (Figure 5.2 A).  
I noted alpha waveforms when the rats were deeply relaxed or about to fall sleep, with notable 
enhanced spectral power at 8 Hz (Figure 5.2 B). Characteristic slow wave oscillations in the 
2 – 4 Hz range (Delta waves) were seen when rats were sleeping (Figure 5.2 C). 
The most extreme change observed was the marked reduction in ECoG activity when rats 
were anaesthetised (Figure 5.2 D) and the burst suppression observed when rats were exiting 
or entering a deeply anaesthetised state (Figure 5.2 E).  
  






Figure 5.1 Setup and procedure for recording ECoG in freely moving rats. 
A) OSI wireless transmitter; black battery pack, transmitter coil, recording electrode (orange) and reference 
electrode (black). B) The end of each electrode was placed through a burr hole in the skull into the brain 
parenchyma, where it was secured in place either by a cannula or by a screw. C) The wireless transmitter body 
was placed into a subcutaneous pocket over the dorsum from which the electrode wires were subcutaneously 
tunnelled to the cranium where each was fixed in place over their designated burr hole. D) The reference electrode 
was placed in the left hemisphere at bregma -4.44 mm. F) The recording electrode was placed in the right 
hemisphere at bregma -6.96 mm. E) The setup of two rat cages side by side inside a faraday cage (to reduce 
electrical noise) with the green receiver coil and signal transduction and recording equipment above. 
 










Figure 5.2 Characterisation of recorded ECoG in freely moving rats. 
A) Characteristic baseline ECoG. B) Alpha waves with a predominant frequency of 8 Hz were observed when rats 
were relaxed. C) Delta waves with a predominant frequency of 3 Hz were observed when rats were sleeping. D) 
Suppression of ECoG was observed when rats were fully anaesthetised. E) Characteristic “burst suppression” 
was observed when rats were lightly anaesthetised or waking from anaesthesia. 




 CHARACTERISATION OF RECORDED ECOG FOR AUTOMATED SEIZURE 
DETECTION IN FREELY MOVING RATS.  
A batch classifier was used to automatically identify and classify different waveforms, but most 
specifically ictal-like events. An ‘Event library’ of examples was built for the batch classifier to 
use to identify each type of ECoG event. The Event Classifier application (OSI) was used to 
do the batch classification by classifying 1 s segments of ECoG according to several metrics 
(coastline, intermittency, coherence and spikiness) enabling similar events to cluster together 
when plotted according to the metrics. Each type of event (e.g. chewing artefact, ictal-like 
events) formed separate clusters (coloured accordingly, Figure 5.3 A). Also depicted are 
example traces of baseline and ictal-like activity from the library as well as the type of ECoG I 
saw when the rats were grooming (and therefore touching their headpieces). 
To further ensure the recording set up and batch classifier could reliably detect seizures should 
the injection of T. crass. result in them, one rat was injected intracranially with picrotoxin 
(400 nl, 10 µM), an excitotoxin, to serve as a positive control. Seizures (such as the one 
depicted in Figure 5.3 B & C) were recorded for 2 hours before they ceased spontaneously.  
These ECoG recordings demonstrated the distinct repetitive spikes characteristic of 
seizure-states (Figure 5.3 C) reflecting ictal activity. Seizures differed in length; some could 
be approximately 30 seconds long (Figure 5.3 B) whilst others were shorter (Figure 5.3 D). 
This demonstrated that my recording system could sensitively detect seizure activity should it 
occur. 
 
 INJECTION OF TAENIA CRASSICEPS HOMOGENATE DOES NOT RESULT IN THE 
DEVELOPMENT OF SEIZURE ACTIVITY IN VIVO. 
Confident in my ability to detect seizures, I next proceeded with the full experimental timeline. 
This included 12 weeks of ECoG recordings in the following manner. 2 weeks of baseline 
recordings were performed post electrode implantation, following this all the animals (both 
control and experimental groups) were injected intradermally with T. crass. homogenate in 
Freund’s incomplete adjuvant (100 µl) at the same time experimental animals received 
intracranial injections of T. crass. homogenate (600 nl per injection site, maximum of 1.8 µl) 
whilst control animals received identical injections of PBS containing an equivalent quantity of 
endotoxin as the T. crass. homogenate. 2 weeks later, and 2 weeks after that, the animals 
received further repeat intracranial injections. For the final intracranial injection, injected 
volumes were doubled. Following a further 6 weeks of ECoG recordings (i.e. a total of 12 




weeks) animals underwent a seizure threshold test using intracranial injection of picrotoxin 
(Figure 5.4 A).    
The wireless transmitter technology made it possible to record 24 hours/day, yielding a 
significant amount of data to process but safeguarding the emergence of even subtle 
differences between groups. First I quantified the number and frequency of 1 s segments 
classified as ictal-like events in T. crass. injected vs control animals. These ictal-like events 
were 1 s segments of ECoG recordings which met the classification criteria as demonstrated 
in Figure 5.4 A, but which did not necessarily reflect actual seizures. Although there was 
significant variability between animals, the mean number of ictal-like events detected per day 
for the T. crass. and control groups did not differ substantially over the course of the 12 week 
study and did not differ significantly from one another (Figure 5.4 B). In addition, the number 
of ictal-like events did not increase following each intracranial injection of T. crass. The number 
of ictal-like events detected was a median of 1952 events per day (IQR 1588 – 2225, N = 8) 
for the T. crass. group and a median 1332 events per day (IQR 1196 – 1386, N = 3) for the 
control group. The large majority of these likely reflect false positives as I designed the library 
in order to stringently limit false negatives, as I wanted to be sure to capture all possible 
seizures, which were defined as 5 consecutive ictal-like events (see below).  
The T. crass. and control groups also do not differ in terms of the number of ictal-like events 
per hour over the 12 weeks (Figure 5.4 C). When the seizure-threshold test was conducted 
on Day 89 by injecting picrotoxin, it was clear that the number of ictal-like events detected 
increased dramatically. This confirmed the ability of the algorithm to detect possible seizures.  
In order to possibly detect actual seizures, I used the batch-classifier to find instances where 
five 1 s ictal-like events occurred in succession, this would represent a 5 s long event with a 
strong likelihood of being a seizure. When these were detected, I visually verified each to rule 
out false positives (Figure 5.4 D). In this manner I observed that despite continuous 
recordings, 24 hours a day over 12 weeks (3 months), none of the animals had seizures. Both 
groups had a median of 0 detected seizures until the seizure-threshold test with picrotoxin, 
during which the T. crass. and control groups had a median of 7.50 (IQR 0 – 66.50, N = 6) 
and 9.00 (IQR 1 – 20.00, N = 3) seizures per hour, respectively, Figure 5.4 D). This revealed 










Figure 5.3 Characterisation of recorded ECoG for automated detection of seizures in freely moving rats. 
A) Batch classification utilised an ‘event library’  consisting of specific examples of 1 s traces recorded and 
identified as having occurred during different activities (ictal, grooming, baseline etc.) plotted here according to 
two of the four classification metrics used, spikiness and coherence. Note how the different activities cluster 
separately. B) Example of a definitive seizure recorded following picrotoxin injection to verify that the equipment 
could detect seizures reliably. C) A portion of (B) expanded to show the repetitive synchronous waveforms 











Figure 5.4 Injection of Taenia crassiceps homogenate did not result in the development of seizures in 
vivo. 
A) ECoG was recorded from 10 rats for up to 12 weeks and analysed for ictal-like events to assess whether 
intracranial injection of Taenia crassiceps has any effect on neuronal circuitry, compared to the control condition. 
Following the surgery, two weeks of baseline recording were performed before the first injection both intradermally 
and intracranially. Thereafter, two more injections were performed at two week intervals followed after six weeks 
by the seizure threshold test. B) The number of detected ictal-like events per day did not differ between the Taenia 
crassiceps (T. crass.) group (n=6) and the control group (n=4) at any time interval during the 12 week experiment. 
C) The number of ictal-like events per hour did not differ significantly between the groups but did increase 
dramatically as a result of the picrotoxin injection at the end of the 12 weeks. D) The number of visually verified 
five second long ictal-like events was zero for both groups until the seizure threshold test, during which the two 
groups did not have a statistically different number of seizures. Values with means ± SEM; ns = not significant, 
n=10. 
 




 TAENIA CRASSICEPS HOMOGENATE DOES NOT AFFECT THE SEIZURE 
THRESHOLD OF NEURONAL NETWORKS IN VIVO.  
Having determined that intracranial injection of T. crass. homogenate did not result in the 
generation of seizures I next wanted to assess whether it could alter neuronal networks in 
such a way as to make the brain more susceptible to seizures initiated via other means. That 
is, could the T. crass. homogenate lower the seizure threshold? To do so I used intracranial 
injection of picrotoxin at a relatively low dose, to potentially trigger seizures in the animals. 
Therefore, after the 12 weeks of ECoG recordings, 1 intradermal injection of T. crass., 3 
intracranial injections of T. crass./control saline, rats were briefly anaesthetised and injected 
with 400 nl of picrotoxin (10 µM, ic) to induce mild seizures lasting a couple of hours. 
Recordings were analysed for seizure activity using the batch classifier as before. The bulk of 
the animals developed pronounced electrographic seizure activity in response to the picrotoxin 
injection (Figure 5.5 A). 
The number of ictal-like events that lasted for 1 or more seconds was determined for each rat, 
following picrotoxin injection. The median number of picrotoxin-induced ictal-like events per 
hour for the T. crass. and control groups were 361.8 (IQR 65.0 – 844.1, N = 6) and 390.0 (IQR 
348.0 – 523.5, N = 3), respectively, and were not significantly different from one another 
(p > 0.05, Mann-Whitney U test, Figure 5.5 B). 
The median number of picrotoxin-induced seizures (a seizure was detected when at least five 
consecutive ictal-like events occurred) per hour for the T. crass. and control groups were 7.50 
(IQR 0 – 66.50, N = 6) and 9.00 (IQR 1.00 – 20.00, N = 3), respectively, and were not 
significantly different from one another (p > 0.05, Mann-Whitney U test Figure 5.5 C). 
The median picrotoxin-induced seizure duration for the T. crass. and control groups were 
13.38 (IQR 0 – 20.99, N = 6) and 15.20 (IQR 14.00 – 32.00, N = 3), respectively, and were 
not significantly different from one another (p > 0.05, Mann-Whitney U test, Figure 5.5 D).  
As T. crass. homogenate did not result in a difference in the number or duration of picrotoxin 
induced seizures I could conclude that T. crass. homogenate did not appear to make the 












Figure 5.5 Taenia crassiceps homogenate did not affect the seizure threshold of neuronal networks in 
vivo. 
A) An example ECoG trace following picrotoxin injection with a portion expanded below (blue box) to show three 
distinct seizures of differing lengths. B) The number of picrotoxin-induced ictal-like events (ictal-like events are 
1 s of ECoG trace with the features of ictal activity) (per hour was not significantly different between the Taenia 
crassiceps (T. crass.) group (n=6) and control group (n=3). C) Picrotoxin-induced seizures were detected as at 
least 5 consecutive ictal-like events, which could last five seconds or longer. The number of these did not differ 
significantly between the groups. D) The picrotoxin-induced seizure duration was not different between T. crass. 
and control groups.  Values with means ± SEM; ns = not significant, n=9. 
  




 ASTROCYTE STAINING WAS NOT AFFECTED BY TAENIA CRASSICEPS 
HOMOGENATE INJECTION. 
Since T. crass. does not result in the generation of seizures or indeed in a predisposition to 
seizures within our 12 week model, I next wanted to assess whether it could result in any 
changes to the surrounding glial cells, which could constitute a neuroinflammatory response. 
Astrocytes respond to tissue injury and foreign antigens.  Their dysregulation may contribute 
heavily to the generation of seizure activity (Sofroniew 2005) and T. solium larval product has 
been shown to modulate the release of chemokines from astrocytes (Uddin et al. 2005). 
I therefore fluorescently labelled astrocytes using the anti-GFAP antibody. Glial fibrillary acidic 
protein (GFAP) is an intermediate filament protein predominantly expressed in astrocytes and 
clearly delineates the major astrocyte processes. It is a good indicator of glial scar formation 
as GFAP expression is typically increased surrounding areas of damage or neuroinflammation 
(Sofroniew 2005). 
Tile scan images were taken of coronal sections of the brains of animals, which included the 
tract in the cortex made by the cannula and recording electrode in the right hemisphere (Figure 
5.6 A). Higher magnification images (200x magnification) were taken of the area just below 
the electrode tract where the T. crass. homogenate / saline was injected to measure the 
amount of fluorescence associated with GFAP antibody staining. In addition, similar high 
resolution images were taken from a corresponding area in the left hemisphere (LH). The 
images taken of the LH, where no cannula or electrode had been placed, were used to 
normalise fluorescence measurements and account for any differences in staining between 
animals or slices (Figure 5.6 A). These normalised average fluorescence values for each 
image might reflect the number or activation status of astrocytes in the slice. The median 
normalised average GFAP fluorescence for the T. crass. and control groups were 111.3 % of 
LH (IQR 96.10 – 118.5 % of LH, N = 12) and 114.4 % of LH (IQR 108.6 – 145.5 % of LH, 
N = 6) respectively, and were not significantly different from one another (p > 0.05, 
Mann-Whitney U test, Figure 5.6 B). 
I then analysed the number of pixels above a particular fluorescence threshold for each image 
in order to determine whether one condition potentially resulted in more astrocytes, more 
astrocytic processes, or more astrocytic scar material being present. Again values were 
normalised for each slice against a corresponding region from the opposite hemisphere. The 
median normalised GFAP-labelled pixels above threshold for the T. crass. and control groups 
were 179.5 % of LH (IQR 102.5 – 352.5 % of LH, N = 12) and 158.1 % of LH (IQR 82.73 – 
512.5 % of LH, N = 6), respectively and were not significantly different from one another 
(p > 0.05, Mann-Whitney U test, Figure 5.6 C). The number of astrocytes or the amount of 




GFAP expressed appears to not have been altered by intracranial injection of T. crass. 
homogenate.  
 
  MICROGLIAL STAINING WAS AFFECTED BY TAENIA CRASSICEPS 
HOMOGENATE INJECTION. 
Microglia, as the resident macrophages of the nervous system, play an important role in 
epileptogenesis. Multiple studies suggest that neuroinflammation and excitability have a 
bi-directional effect on one another (Vezzani et al. 2011; Sheng et al. 1994; Ravizza et al. 
2005; M. G. De Simoni et al. 2000; Balosso et al. 2008; Cerri et al. 2016; Maroso et al. 2011). 
To assess potential microglial changes in my model, I fluorescently labelled microglia using 
the anti-Iba1 antibody. Ionized calcium binding adaptor molecule 1 (Iba1) is a protein that is 
involved in the phagocytic process (Ohsawa et al. 2004). It is found in all microglia, including 
at rest, but its expression is increased when microglia are classically activated. As such, 
increased Iba1 staining is indicative of an inflammatory response. 
As before, tile scan images were acquired of coronal sections of the brains of animals, which 
included the injection tract in the cortex made by the cannula and recording electrode in the 
right hemisphere (Figure 5.7 A). Higher magnification images (200x magnification) were taken 
of the area just below the electrode tract where the T. crass. homogenate / saline was injected 
to measure the amount of fluorescence associated with Iba1 antibody staining. Again, similar 
high magnification images were taken from a corresponding area in the left hemisphere in 
order to normalise fluorescence measurements and account for any potential differences in 
staining between slices (Figure 5.7 A).  The normalised average Iba1 fluorescence just below 
the injection site might represent the number or activation status of microglia. The median 
normalised average Iba1 fluorescence for the T. crass. versus the control groups was 114.0 
% of LH (IQR 107.3 – 119.6 % of LH, N = 12) and 103.7 % of LH (IQR 99.13 – 111.0 % of LH, 
N = 6) respectively, and were not significantly different from one another (p > 0.05, Mann-
Whitney U test, Figure 5.7 B).  
I then also analysed the number of pixels above threshold for each image in order to ascertain 
whether one group might have had more numerous or enlarged cells. Once again values were 
normalised for each slice against a corresponding region from the opposite hemisphere. The 
median normalised number of Iba1-labelled pixels above threshold was increased for the 
T. crass. as compared to control groups (144.6 % of LH [IQR 104.5 – 225.1 % of LH, N = 12] 
versus 66.0 % of LH [IQR 52.04 – 105.3 % of LH, N = 6]). This was a statistically significant  






Figure 5.6 Astrocytes were not affected by Taenia crassiceps homogenate injection. 
Rats were transcardially perfused and the brains processed and frozen for sectioning at 40 µm thickness. 
Fluorescent immunohistochemistry was then performed on the slices labelling astrocytes with an antibody against 
glial fibrillary acidic protein (GFAP), green. A) Top, overview tile scan using a confocal microscope of a coronal 
section containing both hemispheres. Bottom, higher magnification images (200x) were taken from specific 
regions of interest in the left and right hemispheres for average fluorescence and pixel comparisons. B) The 
average GFAP fluorescence from the region of interest below the Taenia crassiceps (T. crass.) injection site 
(normalised by an equivalent region of interest from the non-injected hemisphere) was not statistically different 
from that of the control group. C) The number of pixels with fluorescence values above a certain threshold from 
the same region of interest (again normalised by an equivalent region from the non-injected hemisphere) also did 
not differ significantly between the groups indicating that the astrocytes appear unaffected by the presence of 
Taenia crassiceps homogenate. Values with means ± SEM; ns = not significant, n=8. 
 
 





Figure 5.7 Microglial staining was affected by Taenia crassiceps homogenate injection. 
Rats were transcardially perfused and the brains processed and frozen for sectioning at 40 µm thickness. 
Fluorescent immunohistochemistry was performed on the brain slices labelling astrocytes with an antibody 
against ionized calcium binding adaptor molecule 1 (Iba1), magenta. A) Top, overview tile scan using a confocal 
microscope of a coronal section containing both hemispheres. Bottom, higher magnification images (200x) were 
taken from specific regions of interest in the left and right hemispheres for average fluorescence and pixel 
comparisons. B) The average Iba1 fluorescence from the region of interest in the hemisphere injected with Taenia 
crassiceps (T. crass.) (normalised by the non-injected hemisphere) was not statistically different from that of the 
control group. C) However, the number of pixels with fluorescence values above threshold (and also normalised 
for the non-injected side) was significantly higher in the Taenia crassiceps group indicating either an increase in 
the number of microglia or that the size of microglial cells had increased. Values with means ± SEM; ns = not 
significant, n=8. 
  




difference (p = 0.023, Mann-Whitney U test, Figure 5.7 A). This could indicate either an 
increase in the number of microglial cell bodies or an increase in the size of the cell bodies, or 
the size and number of their processes.  
  
 MICROGLIAL POPULATION SIZE AND SPATIAL CLUSTERING WERE 
UNAFFECTED BY INJECTION OF TAENIA CRASSICEPS HOMOGENATE.  
Given the difference observed above in terms of Iba1-labelled pixels above threshold, I next 
sought to investigate whether this might be due to a change in the number or distribution of 
microglia following cortical T. crass. injection. To do so I performed further imaging at 630x 
magnification (using an oil immersion lens) of the area between the injection tract (above) and 
a white matter tract (below, both blacked out) (Figure 5.8 A). Microglia were then manually 
counted by placing a turquoise dot onto each and using Image J’s count, area and nearest 
neighbour functions (Figure 5.8 B). 
The median microglial density for the T. crass. and control groups were 674.4 cells/mm2 (IQR 
539.7 – 768.6 cells/mm2, N = 5) and 546.4 cells/mm2 (IQR 422.4 – 646.5 cells/mm2, N = 3), 
respectively and were not significantly different from one another (p > 0.05, Mann-Whitney U 
test, Figure 5.8 C). 
Since the number of cells did not differ between conditions I then sought to investigate whether 
the way the cells were distributed spatially might have differed. To determine this I performed 
several analyses. The first was a nearest neighbour measurement, which computes the 
distance to the closest neighbouring cell for each cell. The median nearest neighbour distance 
for the T. crass. and control groups were 25.70 mm2 (IQR 24.91 – 29.17mm2, N = 5) and 
28.35 mm2 (IQR 25.93 – 33.10 mm2, N = 3), respectively and were not significantly different 
from one another (p > 0.05, Mann-Whitney U test, Figure 5.8 D). Next I computed the 
microglial spacing index which indicates how clustered (higher value) or spaced out (lower 
value) the cells are. The median microglial spacing index for the T. crass. and control groups 
were 4.53 AU (IQR 4.44 – 4.78 AU, N = 5) and 4.39 AU (IQR 4.35 – 4.63 AU, N = 3), 
respectively and again were not significantly different from one another (p > 0.05, Mann-
Whitney U test, Figure 5.8 E). Thus the intracranial injections of T. crass. did not appear to 
alter the number or spread of microglia in the vicinity of the injection site. 
 




 TAENIA CRASSICEPS HOMOGENATE INJECTION INDUCED CHANGES IN 
MICROGLIAL MORPHOLOGY.  
In order to investigate if there were any T. crass. induced changes to the morphology of the 
microglia I imaged approximately 20 individual microglia per slice again at 630x magnification 
(using an oil immersion lens). The imaged microglia were from the same area, i.e. surrounding 
the injection tract. I observed that the microglial processes appeared to be more elaborate and 
spread out further in the control group as compared to the T. crass. group (Figure 5.9 A & B). 
One way to quantitatively analyse morphological changes is to measure the soma size and 
the spread of the microglial processes. I therefore traced out the soma for each cell in order 
to calculate its size (Figure 5.9 C). A polygon was then also drawn connecting the distal 
processes in order to calculate the process arbour area and shape (Figure 5.9 C). 
The median arbour area for the T. crass. group was significantly smaller than the control 
group, at 680.4 µm2 (IQR 369.1 – 1081 µm2, N = 99) and 1156 µm2 (IQR 866.1 – 1501.0 µm2, 
N = 62), respectively (p < 0.0001, Mann-Whitney U test, Figure 5.9 D). This is of interest as a 
smaller arbour area could result from the retracting of microglial processes, which is a typical 
neuroinflammatory phenotype (Hui et al. 2019).  
The shape of the microglial arbours could also potentially change as a result of microglial 
activation. I therefore also calculated the arbour circularity for each cell. The median arbour 
circularity for the T. crass. and control groups were 0.75 AU (IQR 0.68 – 0.81 AU, N = 99) and 
0.76 AU (IQR 0.66 – 0.80 AU, N = 62), respectively and were not significantly different from 
one another (p > 0.05, Mann-Whitney U test, Figure 5.9 E).  
It is also possible that the microglial soma sizes could be altered. I found that the median soma 
area for the T. crass. and control groups were 150.1 µm2 (IQR 119.5 – 222.3 µm2, N = 99) and 
168.7 µm2 (IQR 130.3 – 215.5 µm2, N = 62), respectively and were not significantly different 
from one another (p > 0.05, Mann-Whitney U test, Figure 5.9 F). This means that even though 
the T. crass. group have shorter, retracted, processes their cell bodies were not enlarged 
compared to controls.  
A further metric to quantify possible morphological differences between microglia is the 
morphological index. This is calculated by dividing the soma area by the arbour area. The 
median morphological index for the T. crass. and control groups were 0.24 AU (IQR 0.14 – 
0.46 AU, N = 99) and 0.16 AU (IQR 0.11 – 0.22 AU, N = 62), respectively and were significantly 
different from one another (p < 0.0001, Mann-Whitney U test, Figure 5.9 G). This measure 
demonstrates that the T. crass. group had shortened/retracted microglial processes relative 
to their soma size as compared to the control condition. This measure provides evidence that 




T. crass. injection caused microglia to have retracted processes, one morphological 




Figure 5.8 Microglial population size and spatial distribution are unaffected by injection of Taenia 
crassiceps homogenate. 
A) Confocal microscopy image of microglia stained with Iba1 at 630x magnification from a region just below the 
injection tract. Accurate area measurements were taken, excluding the injection site and any white matter tracts, 
using Image J software. B) The number of microglia with the images were manually counted by placing a dot 
(cyan) on top of each microglial cell. C) The microglial density (the number of cells divided by the area) was 
calculated and found not to differ between Taenia crassiceps (T. crass.) and control groups. D) The nearest 
neighbour calculation in Image J was used to analyse how the cells were dispersed and also did not differ between 
the groups. E). The microglial spacing index (a metric to test for clustering of cells) did not differ statistically 
between the Taenia crassiceps and control groups. Values with means ± SEM; ns = not significant, n=8. 
 








Figure 5.9 Taenia crassiceps homogenate injection induces changes in microglial morphology. 
A) Confocal microscopy image at 630x magnification of an Iba1-labelled microglial cell from the Taenia crassiceps 
(T. crass.) group showing retracted processes. B) An Iba1-labelled microglial cell from a control showing a large 
arbour area with extended processes. C) An image showing the tracing of the soma and process arbour (inner 
and outer lines respectively) used to calculate the soma and arbour areas respectively. D) The arbour area was 
significantly smaller in the Taenia crassiceps group, possibly suggestive of activation of the microglia. E) The 
arbour circularity did not differ significantly between the groups. F) The soma area was not significantly different 
between the groups. G) The morphological index (calculated as the area of the soma divided by the area of the 
arbour) was significantly greater in the Taenia crassiceps group, likely because they on average had smaller 
arbour areas, demonstrating that Taenia crassiceps results in a retraction of microglial processes possibly 
indicative of inflammation. Values with means ± SEM; ***p<0.0001, ns = not significant, n=99 cells from 5 rats 
and 62 cells from 3 rats for the Taenia crassiceps and control groups, respectively.  





In Chapter 4 I determined that T. crass. homogenate prepared from viable larvae had no effect 
on the excitability of neurons or neural networks following a 24 hour treatment in an 
organotypic brain slice preparation, which necessarily lacked the ability to generate an 
adaptive immune response.   In this chapter I used continuous ECoG recordings, seizure 
threshold tests and post-mortem immunohistological analysis to determine whether the serial 
intracranial injection of T. crass. homogenate in vivo could evoke seizures, modify neuronal 
networks or drive neuroinflammatory changes. 
My most important finding was that despite 12 weeks of continuous ECoG recordings, none 
of the animals displayed electrographic seizure activity. This was despite several 
manipulations to both maximise the likelihood of evoking seizures and the likelihood of 
detecting them. Firstly, in order to “prime” the adaptive immune system, and to maximise the 
chance of evoking an inflammatory response to the intracranial injection of T. crass. 
homogenate, all animals received an intradermal injection of T. crass. homogenate in 
incomplete Freund’s adjuvant, which would allow for sustained release of T. crass. antigen in 
the animals. Secondly, animals received at least three injections of T. crass. homogenate (2 
weeks apart) into the right visual cortex. Thirdly, during each injection session three of the 
animals received T. crass. homogenate injections into three separate brain areas (left and 
right visual cortex and right hippocampus). These animals therefore received a total of 9 
intracranial injections of T. crass. homogenate over 6 weeks, with double the volume in the 
final injection session. Finally, by making use of wireless telemetry technology to measure 
ECoG continuously, i.e. 24 hours a day, and by making use of a sophisticated automated 
detection algorithms I could be sure that if any seizures did occur during the 12 week period 
they would be detected. In addition, the frequency of short ictal-like events could also be 
detected and compared within animal (i.e. prior to and following T. crass. homogenate 
injection) as well as between control and T. crass. injected groups. Despite all of these 
measures I found that none of the animals experienced seizures and there was no detectable 
difference in ictal-like events following T. crass. injection, or between T. crass. injected and 
control animals. 
I could therefore conclude that at least in my system, T. crass. homogenate did not evoke 
detectable changes in neuronal network function in vivo. Why was this the case? Firstly, it is 
likely that glutamate homeostasis mechanisms were able to deal with the volumes and 
concentrations of glutamate in the T. crass. homogenate to prevent any long-term 
epileptogenic processes from occurring. Secondly, beyond glutamate, it is still possible that I 
did not allow sufficient time for seizures to develop following T. crass. homogenate injection, 




as in human patients this can often take several years. This is unlikely as according to my 
calculations (see Chapter 5.1) 12 weeks in a rat should be roughly equivalent to several years 
in a human patient. Furthermore, I also saw no trends or increases in the number of short 
ictal-like events detected over time following T. crass. homogenate injection. Following the 
picrotoxin injection at 12 weeks (the seizure threshold test) there was no difference in the 
number or duration of seizures evoked between T. crass. and control groups. Together this 
suggests that injection of T. crass. homogenate did not appear to enhance excitability within 
brain circuits and was therefore unlikely to evoke seizures at a later time point. Never-the-less, 
in the future the recording period could be lengthened for an in vivo study by intermittently 
turning the batteries of the wireless transmitters off, whilst being wary that this may reduce the 
reliability of capturing seizure events. Thirdly, it is possible that as could have been the case 
for Chapter 4, I injected T. crass. larvae of the wrong “state” into the brain. As described before, 
whilst Taenia larvae are viable within the brain, human patients can often be asymptomatic 
(Stringer et al. 2003), and that it is only once the larvae die naturally, or are killed using 
anti-helminthic agents that the likelihood of seizures occurring increases (Verma et al. 2010; 
Nash, Pretell, and Garcia 2002). In these experiments, the T. crass. homogenate used was 
prepared from live, viable larvae, which were freeze-thawed to lyse the cells before 
homogenization. Utilising homogenate from dead or dying larvae may have had a different 
outcome. In support of this idea, Stringer et al. (2003) demonstrated that early stage T. crass. 
granulomas, presumably containing material from dead or dying T. crass. larvae and 
surrounding inflammatory cells, evoked acute seizures when injected intracranially in rats. 
There are several caveats to this work however, including the fact that seizures were elicited 
acutely (no chronic recordings were performed), and the granulomas were developed in the 
peritoneum of mice and not in the brain parenchyma itself. Fourthly, it is possible that larvae 
of the ORF strain of T. crass. are simply not as virulent as T. solium, the pathogenic agent in 
humans. Indeed, Verastegui et al. (2015) showed that injection of T. solium ova intracranially 
into rats resulted in the development of seizures in 9% of animals (2 of 23 animals infected). 
This could suggest that a) as very few animals developed seizures in the Verastegui et al. 
study we did not use sufficient numbers of animals in our study to detect this low incidence 
(only 6 animals were injected with T. crass. homogenate due to cost constraints associated 
with the transmitters) or b) that the species of cestode is important for seizure development 
(i.e. T. solium vs T. crassiceps) or c) that it is important to inject ova rather than larval 
homogenate. Future work could seek to address these potential limitations by injecting 
different types of cestode material in animals where continuous ECoG recordings can be 
performed. 




A reasonable, but intriguing interpretation of my data is that the T. crass. homogenate I 
injected failed to evoke a sufficiently large inflammatory response or in fact had 
anti-inflammatory properties. Indeed, my immunohistochemical analysis revealed no changes 
in astrocyte staining between T. crass. and control animals. In contrast however, I did observe 
some changes in microglial staining and morphology between the groups, namely that the 
processes of microglia in T. crass. injected animals were more retracted than in controls. This 
is in line with the literature, which reports that microglia take on a more amoeboid shape and 
retract their processes when in an activated state (Hui et al. 2019).  This suggests that the 
T. crass. homogenate did drive some phenotypic changes constituting part of a 
neuroinflammatory response, which is broadly consistent with neuroinflammation ultimately 
observed in NCC (Shabab et al. 2017; Feng et al. 2019).  
A reasonable question, however, which I was unable to answer, is whether the injection of 
foreign material from a different organism, or even endogenous proteins not normally found in 
the brain might have elicited more of a neuroinflammatory response as compared to that 
observed following T. crass. homogenate injections. This is because our control injections, the 
point of comparison, were saline containing an equivalent level of endotoxin as the T. crass. 
homogenate. For example, serum albumin, robustly activates microglia and astrocytes if it 
enters the extravascular space within the brain parenchyma following injury (Ralay Ranaivo 
and Wainwright 2010; Weissberg et al. 2016; Ivens et al. 2007; Seiffert et al. 2004). It is likely 
that other foreign proteins may have generated more of an inflammatory response than 
T. crass. Indeed, Taenia larvae have likely evolved multiple mechanisms to modulate and 
prevent host immune responses to maintain their viability in situ (Peón, Ledesma-Soto, and 
Terrazas 2016). For example, homogenate from viable cestode larvae has been shown to 
prevent activation of microglia (Y. Sun et al. 2014). It is therefore possible that one explanation 
for our inability to elicit seizure activity and a robust neuroinflammatory response is because 
the T. crass. homogenate prepared from larvae also contain factors with anti-inflammatory 
properties. 
Taken together, in this chapter I demonstrated that serial intracranial injection of T. crass. 






6 OVERALL DISCUSSION AND CONCLUSIONS 
In this thesis I have used patch-clamp electrophysiology, and calcium imaging in hippocampal 
organotypic brain slice cultures to demonstrate that Taenia larval products cause neuronal 
depolarization and can initiate seizure-like events via glutamate receptor activation. Glutamate 
assays revealed that both T. crass. and T. solium larvae contain and release considerable 
quantities of glutamate (Chapter 3). A 24 hour treatment with 50 µg/ml of T. crass. larval 
homogenate, however, was not enough to evoke any changes in neuronal membrane 
properties, firing rates or network excitability (Chapter 4). Furthermore, repeated intracranial 
injections of T. crass. larval homogenate also affected no observable change on nearby 
neurons as measured by ECoG and wireless telemetry over 12 weeks. 
Immunohistochemically stained microglia in the surrounding area of T. crass. injection showed 
signs of activation indicative of a mild inflammatory response (Chapter 5), but this was not 
observed in astrocytes. I discuss below how these seemingly divergent findings may fit 
together and confer what future work could be performed to further elucidate and characterise 
seizure development in NCC. 
Clinical evidence and animal models conclusively demonstrate that the presence of cestode 
larvae in the brain can result in the generation of seizures (Verastegui et al. 2015; Nash et al. 
2015). Importantly, the majority of previous work has centred around the host inflammatory 
response and how this plays a role in seizure generation (Stringer et al. 2003; Robinson et al. 
2012). Whilst this is likely important, it does not preclude the involvement of additional or 
exacerbating pathogenic mechanisms for seizure generation and epileptogenesis in NCC. In 
this thesis I identified that Taenia larvae have a direct excitatory effect on neurons via 
glutamatergic signalling. This is important as the central role of glutamatergic signalling in 
epileptogenesis has conclusively been shown using multiple cell culture (D. A. Sun, Sombati, 
and DeLorenzo 2001; Sombati and DeLorenzo 1995; DeLorenzo, Pal, and Sombati 1998), 
slice (Anderson et al. 1986; Ziobro, Deshpande, and DeLorenzo 2011; Stasheff et al. 1989), 
and in vivo models of epilepsy (M. J. Croucher and Bradford 1990; Martin J. Croucher et al. 
1988; Rice and Delorenzo 1998).   
Clinically, in addition to NCC, the other major causes of adult acquired epilepsy are stroke, 
traumatic brain injury and CNS tumours (Hauser, Annegers, and Kurland 1991; Forsgren et 
al. 2005). In these other causes of acquired epilepsy, glutamatergic signalling and glutamate 




excitotoxicity are thought to be central to the pathogenic process. Glutamate excitotoxicity 
occurs when depolarized, damaged or dying neurons release glutamate, which activate 
surrounding neurons via NMDA and AMPA receptors, resulting in sustained neuronal 
depolarization, Ca2+ influx and the subsequent activation of signalling cascades and enzymes. 
These in turn lead to cell death via necrosis and apoptosis (Ankarcrona et al. 1995), the further 
release of intracellular glutamate and the propagation of the excitotoxic process to 
neighbouring cells. In the neurons that survive, the prolonged exposure to glutamate has been 
shown to cause hyperexcitability and seizures (DeLorenzo, Pal, and Sombati 1998; D. A. Sun, 
Sombati, and DeLorenzo 2001) via multiple mechanisms including enhanced intrinsic 
excitability and NMDA receptor dependent disruption of GABAergic inhibition (Lee et al. 2011; 
Terunuma et al. 2010; Buckingham et al. 2011). Given our finding that Taenia larvae contain 
and release significant quantities of glutamate, it is possible that should homeostatic 
mechanisms for taking up and metabolizing glutamate fail to compensate for larval derived 
glutamate in the extracellular space, similar glutamate-dependent excitotoxic and 
epileptogenic processes that occur in stroke, traumatic brain injury and CNS tumours are likely 
to also occur in NCC.  
Glioma, a common adult primary brain tumour, which typically presents with seizures in over 
80% of patients (Santosh and Sravya 2017), is an intriguing condition for comparison to NCC.  
Glioma tumour cells themselves have been shown to release glutamate into the extracellular 
space via the system xc−cystine-glutamate antiporter (Buckingham et al. 2011). Interestingly, 
there is compelling evidence that tumoural release of glutamate via this mechanism causes 
seizures and in addition, favours glioma preservation, progression and invasion in cases of 
malignant glioma (Sontheimer 2008; Takano et al. 2001; Huang et al. 2013). Analogously, it 
is possible that Taenia larvae in the brain utilize the release of glutamate and the induction of 
glutamate excitotoxicity to facilitate their growth and expansion, with the accompanying effect 
of seizure generation. In the case of glioma, where the mechanism of glutamate release by 
tumour cells is known, pharmacological agents (e.g. sulfasalazine), which block glutamate 
release have considerable potential as therapeutic agents for reducing seizure burden in this 
condition. Therefore, it is important that future work attempts to identify the molecular 
mechanisms underlying the Taenia-specific production of glutamate in order to inform the 
development of new therapeutic strategies to potentially reduce larval expansion and treat 
seizures in NCC. In terms of further elucidating the possible glutamate mechanism of Taenia 
in vivo; glutamate receptor expression could be analysed post treatment in vivo to determine 
whether any glutamate receptors are upregulated and on which cells preferentially. Assessing 
the effect of different levels of environmental glutamate on cestode larval growth would also 
be of interest, in terms of a mechanistic comparison to tumour cells.  




An important consideration is how we might reconcile my findings of continuous glutamate 
release by Taenia larvae with the clinical picture of delayed symptom onset in NCC. In people 
with NCC, acute seizures may be experienced by some immediately following infection whilst 
it takes months to years following initial infection for others (Foyaca-sibat et al. 2009; Stringer 
et al. 2003). This suggests that multiple different, or possibly interacting mechanisms might 
be involved in the epileptogenic process in NCC. Neuroinflammation is one possible 
mechanism that has long been thought to be central to the development of seizures in NCC. 
In support of this, larval suppression of host inflammatory responses explains why many 
patients may remain asymptomatic for years following infection (Garcia, Gonzalez, and 
Gilman 2003). My findings are not at odds with this line of thinking when considering the effect 
of neuroinflammation on extracellular glutamate uptake. In the healthy brain parenchymal 
astrocytes are optimized to maintain extracellular glutamate at low concentrations (Perea and 
Araque 2010). However, the inflammatory transition of astrocytes to a reactive phenotype is 
known to impede their ability to buffer extracellular uptake (Seifert, Carmignoto, and 
Steinhäuser 2010). It is therefore conceivable that cyst-associated reactive astrocytosis may 
gradually erode the ability of homeostatic mechanisms to compensate for larval derived 
extracellular glutamate, resulting in delayed symptom onset in NCC. Astrocytes are usually 
activated by microglial TNF-α and IL-1β release, which places the attention on activated 
microglia (exhibiting retracted processes and enlarged somas) as the first indicator of 
neuroinflammation (Vezzani and Viviani 2015). In my study there was evidence of activated 
microglia in response to the intracranial injection of T. crass. (see Chapter 5), however, the 
astrocytes did not exhibit a characteristic increase in size or GFAP fluorescence (Figure 5.6), 
as has been seen in the literature (Wilhelmsson et al. 2006). The inflammatory response was 
therefore likely still in its early stages because the microglia didn’t have enlarged somas 
(despite their processes being retracted) and the astrocytes had a non-reactive morphology.  
A further way we might explain a delayed onset of epileptogenesis following Taenia infection 
is that the presence of multiple cysts at different stages of development may be required, 
perhaps even multiple rounds of infection. It is common place for a person to suffer with 
different stages of cysts at the same time (Wagner and Newton 2009, Figure 2), whether from 
the same or a different infection. A degenerating larval cyst starting to evoke an inflammatory 
response may on its own not result in seizures. This is because the amount of glutamate 
contained within a larvae is relatively small and may only exert a local effect, despite a 
declining astrocyte glutamate buffering capability. Patients who additionally have a viable cyst 
that is constantly producing glutamate into an environment where astrocytes are unable to 
adequately buffer it, akin to glioma tumoural cells, would possibly be more vulnerable to 
developing seizures. Given that NCC occurs in areas where there is poor sanitation and the 




recognition and diagnosis of the disease can take years, the chance of a person being infected 
multiple times, and thus experiencing cysts at a variety of stages, is a statistical possibility. 
Thus, future work could expose neurons, either in vitro or in vivo, to dead larval product, which 
should activate an immune response, followed by viable larva, which would continually 
produce glutamate.  
In addition to identifying an important role for glutamate in this thesis, I have also demonstrated 
that at the concentrations delivered, other factors within T. crass. homogenate from viable 
larvae do not drive changes in neuronal or network excitability over 24 hrs in vitro or over 12 
weeks in vivo, which I believe is important information for the field. An important limitation of 
my study is that all investigations used only a single type of larval homogenate. It is important 
to note that utilising a different form of the larval product could result in different functional 
effects on neurons in vitro and in vivo. The larvae could be killed in a different way or the 
homogenate prepared in such a way as to preserve the cell wall fraction that in these 
experiments was separated out by centrifuging. Whole dead larvae could be used in the in 
vitro model, but, due to their size, would be difficult to inject intracranially in vivo. Activated 
oncospheres could be injected, as has been done in other models, but may take considerable 
time to develop into larvae and then cysticerci.  
It is clear that there is still considerable uncertainty regarding the precise sequences of events 
leading to seizure onset in NCC. Nonetheless, my thesis has demonstrated the utility of using 
modern techniques in cellular neuroscience such as patch-clamp electrophysiology and 
wireless ECoG together with new models of NCC to study how neuronal networks might be 
affected in this disorder. My findings provide the first evidence that, as is the case with the 
other common causes of adult acquired epilepsy (i.e. stoke, traumatic brain injury and glioma), 
increased extracellular glutamate likely plays an important role in the development of seizures 
in NCC. I hope this thesis will encourage and inform future research studying seizure 
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